[{"doc_id": 1174877, "edit_id": 0, "question": "What is metabolic syndrome?", "category": "omission", "label": "concept"}, {"doc_id": 1174877, "edit_id": 1, "question": "What criteria did the patients meet to be included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 1174877, "edit_id": 2, "question": "What is a unique characteristic of Telmisartan besides its ability to lower high blood pressure?", "category": "concept", "label": "concept"}, {"doc_id": 1174877, "edit_id": 3, "question": "What was the design of the study?", "category": "concept", "label": "procedural"}, {"doc_id": 1174877, "edit_id": 4, "question": "What is the correct term for the percentage of sugar coating on red blood cells?", "category": "concept", "label": "concept"}, {"doc_id": 1291385, "edit_id": 0, "question": "What were the specific dosages of dexamethasone and diclofenac potassium used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 1291385, "edit_id": 1, "question": "What was the design of the study and how did it control for bias?", "category": "concept", "label": "procedural"}, {"doc_id": 1291385, "edit_id": 2, "question": "How did the researchers measure the facial swelling and mouth-opening ability of the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 1618957, "edit_id": 0, "question": "What is the common use of depot somatostatin analogues in treating acromegaly?", "category": "omission", "label": "concept"}, {"doc_id": 1618957, "edit_id": 1, "question": "What were the percentages of patients who had GH levels < 2\u00b75 ng/ml and normalized IGF-1 with lanreotide Autogel\u00ae and microparticles?", "category": "omission", "label": "extent"}, {"doc_id": 1618957, "edit_id": 2, "question": "How long had the patients been using lanreotide microparticles before the study and what type of trial was this?", "category": "concept", "label": "extent"}, {"doc_id": 1618957, "edit_id": 3, "question": "What were the mean GH levels with lanreotide Autogel\u00ae and microparticles?", "category": "concept", "label": "extent"}, {"doc_id": 165418, "edit_id": 0, "question": "What was the condition of the diabetes in the women who participated in the study?", "category": "omission", "label": "concept"}, {"doc_id": 165418, "edit_id": 1, "question": "What specific blood test was used to measure glycemic control in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 2, "question": "What specific health survey was used to evaluate the quality of life in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 3, "question": "What specific mental health evaluations were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 165418, "edit_id": 4, "question": "What specific protein increased in the paroxetine group indicating improved insulin sensitivity?", "category": "concept", "label": "concept"}, {"doc_id": 165418, "edit_id": 5, "question": "Who might benefit from adding paroxetine to their standard diabetes treatment according to the study?", "category": "concept", "label": "consequence"}, {"doc_id": 1774569, "edit_id": 0, "question": "What type of trial was conducted in this study?", "category": "omission", "label": "concept"}, {"doc_id": 1774569, "edit_id": 1, "question": "Who decided the reducing regimens for the detoxification drugs?", "category": "omission", "label": "procedural"}, {"doc_id": 1774569, "edit_id": 2, "question": "What was the risk reduction for non-completion of detoxification if allocated buprenorphine?", "category": "omission", "label": "extent"}, {"doc_id": 1774569, "edit_id": 3, "question": "What was the primary outcome of the study and how was it measured?", "category": "concept", "label": "consequence"}, {"doc_id": 1774569, "edit_id": 4, "question": "How many people were abstinent at three and six months post detoxification?", "category": "concept", "label": "extent"}, {"doc_id": 1868720, "edit_id": 0, "question": "What were the statistical measures that showed the difference in sickness absence between the 'at risk' and 'not at risk' groups?", "category": "omission", "label": "extent"}, {"doc_id": 1868720, "edit_id": 1, "question": "What was the purpose of the surveys that the researchers sent out?", "category": "concept", "label": "procedural"}, {"doc_id": 1868720, "edit_id": 2, "question": "What type of trial were the selected employees included in?", "category": "concept", "label": "concept"}, {"doc_id": 1868720, "edit_id": 3, "question": "At what stage was the intervention implemented?", "category": "concept", "label": "procedural"}, {"doc_id": 1915612, "edit_id": 0, "question": "What were the severity levels of the whiplash injuries in the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 1915612, "edit_id": 1, "question": "What was the maximum dosage of botulinum toxin administered to the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 1915612, "edit_id": 2, "question": "How was the intensity of neck pain measured in the study and what were the specific results?", "category": "concept", "label": "procedural"}, {"doc_id": 1915612, "edit_id": 3, "question": "How was neck mobility measured in the study and what were the specific results?", "category": "concept", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 0, "question": "What theory or model were the interventions based on?", "category": "omission", "label": "concept"}, {"doc_id": 2253708, "edit_id": 1, "question": "What specific measurements were used to assess the effectiveness of the interventions?", "category": "omission", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 2, "question": "What was the specific design of the study?", "category": "concept", "label": "procedural"}, {"doc_id": 2253708, "edit_id": 3, "question": "What was the quit rate for the control group that didn't receive any intervention?", "category": "concept", "label": "extent"}, {"doc_id": 2427034, "edit_id": 0, "question": "From what type of sample was the DNA extracted for the study?", "category": "omission", "label": "concept"}, {"doc_id": 2427034, "edit_id": 1, "question": "How was the H. pylori infection determined in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 2, "question": "How were the mutations of the 23S rRNA gene detected in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2427034, "edit_id": 3, "question": "Besides the A2143G mutation, were there any other specific sequence alterations that were more frequent in the group that received the three-drug treatment?", "category": "omission", "label": "verification"}, {"doc_id": 2427034, "edit_id": 4, "question": "What were the percentages of people in the OA and placebo groups who still had H. pylori infection 7.3 years after OA therapy?", "category": "concept", "label": "extent"}, {"doc_id": 2427034, "edit_id": 5, "question": "What was the exact percentage of people in the OAC group who still had H. pylori infection three years after OAC treatment?", "category": "concept", "label": "extent"}, {"doc_id": 2430614, "edit_id": 0, "question": "What was the health condition of the children who participated in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2430614, "edit_id": 1, "question": "Besides clinical failures and adverse events, what other aspect was compared between the study groups?", "category": "omission", "label": "comparison"}, {"doc_id": 2430614, "edit_id": 2, "question": "What were the specific failure rates for each group, and what is the difference between corrected and uncorrected rates?", "category": "concept", "label": "comparison"}, {"doc_id": 2430614, "edit_id": 3, "question": "What were the specific rates of early treatment failure for each group?", "category": "concept", "label": "extent"}, {"doc_id": 2500257, "edit_id": 0, "question": "What is PNA-FISH?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 1, "question": "What does GPCC stand for in this context?", "category": "omission", "label": "concept"}, {"doc_id": 2500257, "edit_id": 2, "question": "How statistically significant were the results of the study?", "category": "concept", "label": "extent"}, {"doc_id": 2556743, "edit_id": 0, "question": "What measure was used to assess the overall health condition of the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 2556743, "edit_id": 1, "question": "What was the specific target for minimizing the blood pressure changes in the intervention group?", "category": "omission", "label": "concept"}, {"doc_id": 2556743, "edit_id": 2, "question": "What does maintaining a healthy blood flow during major surgeries mean in the context of this study?", "category": "concept", "label": "concept"}, {"doc_id": 2556743, "edit_id": 3, "question": "What does using a ventilator to regulate the pressure changes in the blood vessels mean in the context of this study?", "category": "concept", "label": "concept"}, {"doc_id": 2556743, "edit_id": 4, "question": "How many postoperative complications per patient were there in each group?", "category": "concept", "label": "extent"}, {"doc_id": 2639329, "edit_id": 0, "question": "What was the primary objective of the \u0152DIPE study?", "category": "omission", "label": "concept"}, {"doc_id": 2639329, "edit_id": 1, "question": "What were the exact percentages of patients who experienced treatment-related major adverse events in the active and control groups, and what was the absolute risk reduction?", "category": "concept", "label": "comparison"}, {"doc_id": 2639329, "edit_id": 2, "question": "Was the shorter hospital stay in the active group a result of the study design, and was this difference statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 2652457, "edit_id": 0, "question": "What software was used to develop the computer program for learning about autism?", "category": "omission", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 1, "question": "What were the specific statistical results of the study regarding the retention performance and level of enjoyment of the students who used the computer program?", "category": "omission", "label": "extent"}, {"doc_id": 2652457, "edit_id": 2, "question": "How were the students assigned to either use the computer program or read the leaflet?", "category": "concept", "label": "procedural"}, {"doc_id": 2652457, "edit_id": 3, "question": "What specific statistical methods were used to analyze the data from both groups?", "category": "concept", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 0, "question": "What were the average operative times for both laparoscopic and open pyeloplasty?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 1, "question": "What were the average hospital stays for both laparoscopic and open pyeloplasty?", "category": "omission", "label": "extent"}, {"doc_id": 2699080, "edit_id": 2, "question": "What types of open pyeloplasty were performed in the study?", "category": "omission", "label": "example"}, {"doc_id": 2699080, "edit_id": 3, "question": "What types of scans were used to monitor patients after surgery and when were they performed?", "category": "concept", "label": "procedural"}, {"doc_id": 2699080, "edit_id": 4, "question": "How much pain medication was required by patients in both laparoscopic and open pyeloplasty groups?", "category": "concept", "label": "extent"}, {"doc_id": 2699714, "edit_id": 0, "question": "What were the specific criteria for a child to be included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2699714, "edit_id": 1, "question": "What were the specific A1C levels in the etanercept and placebo groups at the end of the study, and was the difference statistically significant?", "category": "concept", "label": "comparison"}, {"doc_id": 2699714, "edit_id": 2, "question": "What were the specific percent changes in C-peptide area under the curve in the etanercept and placebo groups, and was the difference statistically significant?", "category": "concept", "label": "comparison"}, {"doc_id": 2703617, "edit_id": 0, "question": "Besides waiting times, what other effectiveness measure was the study looking at?", "category": "omission", "label": "concept"}, {"doc_id": 2703617, "edit_id": 1, "question": "How many patients were in the pre-intervention control group and the post-intervention study group?", "category": "omission", "label": "extent"}, {"doc_id": 2703617, "edit_id": 2, "question": "What is the Canadian Triage Acuity Scale (CTAS) and how was it used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2703617, "edit_id": 3, "question": "How significant was the reduction in the number of patients leaving without being seen (LWBS)?", "category": "concept", "label": "extent"}, {"doc_id": 2710065, "edit_id": 0, "question": "What was the initial condition of the patients' urine cultures before the study?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 1, "question": "What specific antibiotic was given to the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2710065, "edit_id": 2, "question": "When were the urine tests conducted after the operation?", "category": "omission", "label": "procedural"}, {"doc_id": 2710065, "edit_id": 3, "question": "What specific procedure was used to remove the small tumors?", "category": "concept", "label": "procedural"}, {"doc_id": 2710065, "edit_id": 4, "question": "What specific type of bladder check-up might not require antibiotics according to the study?", "category": "concept", "label": "concept"}, {"doc_id": 2742700, "edit_id": 0, "question": "What was the initial blood pressure level of the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2742700, "edit_id": 1, "question": "What was the target blood pressure level set for the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 2742700, "edit_id": 2, "question": "What was the specific condition of the participants in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2742700, "edit_id": 3, "question": "What specific blood pressure measurements showed no significant difference among the three groups?", "category": "concept", "label": "comparison"}, {"doc_id": 2742700, "edit_id": 4, "question": "What was the specific goal of the efforts to manage high blood pressure in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2774638, "edit_id": 0, "question": "What was the primary objective of the study?", "category": "omission", "label": "concept"}, {"doc_id": 2774638, "edit_id": 1, "question": "How many black and white postmenopausal women participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 2, "question": "By how much did the CFFFQ overestimate the mean total calcium intake compared to the 24-hour recall?", "category": "omission", "label": "extent"}, {"doc_id": 2774638, "edit_id": 3, "question": "How strong was the correlation between the measures for total daily calcium intake?", "category": "concept", "label": "extent"}, {"doc_id": 2774638, "edit_id": 4, "question": "What percentage of calcium intake comes from dairy for both black and white women?", "category": "concept", "label": "extent"}, {"doc_id": 2784391, "edit_id": 0, "question": "What are some of the reasons critically ill patients lose muscle mass?", "category": "omission", "label": "cause"}, {"doc_id": 2784391, "edit_id": 1, "question": "In which specific patient groups has EMS been shown to be an alternative to active exercise?", "category": "omission", "label": "example"}, {"doc_id": 2784391, "edit_id": 2, "question": "How was the severity of illness in patients determined for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 2784391, "edit_id": 3, "question": "How exactly was muscle mass evaluated in this study?", "category": "concept", "label": "procedural"}, {"doc_id": 2784391, "edit_id": 4, "question": "In which specific patient group does the study suggest EMS could be a useful preventive and rehabilitation tool?", "category": "concept", "label": "concept"}, {"doc_id": 2864284, "edit_id": 0, "question": "Were any other drugs besides chloroquine and dihydroartemisinin-piperaquine administered during the study?", "category": "omission", "label": "verification"}, {"doc_id": 2864284, "edit_id": 1, "question": "What was the main goal of the study and what was the hypothesis?", "category": "omission", "label": "concept"}, {"doc_id": 2864284, "edit_id": 2, "question": "Were there any other factors associated with the recurrence of malaria?", "category": "omission", "label": "cause"}, {"doc_id": 2864284, "edit_id": 3, "question": "What were the specific recurrence rates for each treatment group after eight weeks?", "category": "concept", "label": "extent"}, {"doc_id": 2864284, "edit_id": 4, "question": "How was the superiority of dihydroartemisinin-piperaquine over chloroquine confirmed?", "category": "concept", "label": "verification"}, {"doc_id": 2882922, "edit_id": 0, "question": "How were the events categorized in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 2882922, "edit_id": 1, "question": "How was the sample size for the study determined?", "category": "omission", "label": "procedural"}, {"doc_id": 2882922, "edit_id": 2, "question": "What were the specific characteristics of the patients in each group?", "category": "omission", "label": "concept"}, {"doc_id": 2882922, "edit_id": 3, "question": "Why did some patients stop taking Tamoxifen prematurely?", "category": "concept", "label": "cause"}, {"doc_id": 2882922, "edit_id": 4, "question": "Was the difference in the number of new estrogen-receptor positive breast cancers between the two groups statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 2900076, "edit_id": 0, "question": "What type of anesthesia was used during the Total Knee Arthroplasty procedure?", "category": "omission", "label": "concept"}, {"doc_id": 2900076, "edit_id": 1, "question": "When and how much of the placebo or tranexamic acid was administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 2900076, "edit_id": 2, "question": "What were the specific volumes of drainage fluid for the placebo and tranexamic acid groups?", "category": "omission", "label": "extent"}, {"doc_id": 2900076, "edit_id": 3, "question": "How many units of blood were transfused to the placebo and tranexamic acid groups?", "category": "concept", "label": "extent"}, {"doc_id": 2900076, "edit_id": 4, "question": "How does tranexamic acid lead to significantly fewer blood transfusions?", "category": "concept", "label": "cause"}, {"doc_id": 2967098, "edit_id": 0, "question": "What tools were used to assess the patients' improvement and side effects?", "category": "omission", "label": "procedural"}, {"doc_id": 2967098, "edit_id": 1, "question": "What specific type of mental illness were the patients suffering from?", "category": "concept", "label": "concept"}, {"doc_id": 2967098, "edit_id": 2, "question": "What was the diagnosis of the patients included in the study?", "category": "concept", "label": "concept"}, {"doc_id": 2967098, "edit_id": 3, "question": "How was the improvement of the patients measured?", "category": "concept", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 0, "question": "What type of implants were used in each group?", "category": "omission", "label": "concept"}, {"doc_id": 3118076, "edit_id": 1, "question": "What specific measurements related to the soft tissues in the mouth were taken?", "category": "omission", "label": "procedural"}, {"doc_id": 3118076, "edit_id": 2, "question": "What were the exact success rates of the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 3118076, "edit_id": 3, "question": "Which specific measurement increased significantly more in the second group compared to the first?", "category": "concept", "label": "comparison"}, {"doc_id": 3136370, "edit_id": 0, "question": "What type of medicine do most patients with fibromyalgia use?", "category": "omission", "label": "concept"}, {"doc_id": 3136370, "edit_id": 1, "question": "What specific measures were used to assess the outcomes of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 2, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 3136370, "edit_id": 3, "question": "What statistical methods were used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3136370, "edit_id": 4, "question": "What else, besides the shakes, contributed to the decrease in fibromyalgia symptoms?", "category": "concept", "label": "cause"}, {"doc_id": 3137438, "edit_id": 0, "question": "What type of teeth were used in the study and how was decay simulated?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 1, "question": "What was measured in the samples after one week and three months?", "category": "omission", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 2, "question": "How many teeth were in each group in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3137438, "edit_id": 3, "question": "What statistical method was used to analyze the data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3137438, "edit_id": 4, "question": "Was the increase in leakage after three months statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 3172326, "edit_id": 0, "question": "What was the dosage of ketamine given to the patients and when was it administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 1, "question": "How long did it take for the patients in both groups to request for pain relief for the first time?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 2, "question": "How many pethidine injections were given to the patients in the first 24 hours after the surgery?", "category": "omission", "label": "extent"}, {"doc_id": 3172326, "edit_id": 3, "question": "What was the design of the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3172326, "edit_id": 4, "question": "What type of scale was used to measure the pain intensity?", "category": "concept", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 0, "question": "What was the physical status of the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 1, "question": "What specific anesthetic was used in the study and how was it administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3214395, "edit_id": 2, "question": "What were the target BIS values used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3214395, "edit_id": 3, "question": "What other parameters were recorded during the study?", "category": "concept", "label": "concept"}, {"doc_id": 3214395, "edit_id": 4, "question": "How was the data from the study analyzed?", "category": "concept", "label": "procedural"}, {"doc_id": 3215316, "edit_id": 0, "question": "What is the main symptom that Thalassemia patients suffer from?", "category": "omission", "label": "concept"}, {"doc_id": 3215316, "edit_id": 1, "question": "How significant were the results of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3215316, "edit_id": 2, "question": "What specific conditions is Dhatri Avaleha traditionally used to treat?", "category": "concept", "label": "concept"}, {"doc_id": 3215316, "edit_id": 3, "question": "What are the potential benefits of using Dhatri Avaleha in treating Thalassemia?", "category": "concept", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 0, "question": "What is the most common complication of diabetes?", "category": "omission", "label": "concept"}, {"doc_id": 3232074, "edit_id": 1, "question": "What was the effect of ANGIPARSTM on the Michigan diabetic neuropathy score?", "category": "omission", "label": "consequence"}, {"doc_id": 3232074, "edit_id": 2, "question": "How was the study designed to control for bias?", "category": "concept", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 3, "question": "What specific tests were used to measure the effects of the medicine?", "category": "concept", "label": "procedural"}, {"doc_id": 3232074, "edit_id": 4, "question": "What specific changes were observed in the motor Ulnar nerve in the ANGIPARSTM group?", "category": "concept", "label": "consequence"}, {"doc_id": 3233513, "edit_id": 0, "question": "What was the primary outcome variable in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3233513, "edit_id": 1, "question": "What were the specific results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 3233513, "edit_id": 2, "question": "What were the results of the St George's Respiratory Questionnaire?", "category": "omission", "label": "consequence"}, {"doc_id": 3233513, "edit_id": 3, "question": "How was the study designed?", "category": "concept", "label": "procedural"}, {"doc_id": 3233513, "edit_id": 4, "question": "What were the specific results regarding the different doses of formoterol?", "category": "concept", "label": "consequence"}, {"doc_id": 3269796, "edit_id": 0, "question": "How many medical trainees, experienced doctors, and research technicians were involved in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3269796, "edit_id": 1, "question": "What were the specific average lengths of the bone marrow samples taken out by the OnControl device and the regular needle?", "category": "omission", "label": "comparison"}, {"doc_id": 3269796, "edit_id": 2, "question": "What were the specific average times for the procedures performed by the OnControl device and the regular needle?", "category": "concept", "label": "comparison"}, {"doc_id": 3269796, "edit_id": 3, "question": "What kind of minor problems were encountered in both groups of tests?", "category": "concept", "label": "example"}, {"doc_id": 3357231, "edit_id": 0, "question": "How much isomaltulose or sucrose were the patients asked to consume daily?", "category": "omission", "label": "extent"}, {"doc_id": 3357231, "edit_id": 1, "question": "Were there any other health parameters measured in the study?", "category": "omission", "label": "verification"}, {"doc_id": 3357231, "edit_id": 2, "question": "What was the main thing the researchers were looking at in this study?", "category": "concept", "label": "concept"}, {"doc_id": 3357231, "edit_id": 3, "question": "When were the triglyceride levels measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 0, "question": "What were the specific effects of premeal insulin on U46619-induced platelet P-selectin expression and fibrinogen binding?", "category": "omission", "label": "consequence"}, {"doc_id": 3425422, "edit_id": 1, "question": "What type and dosage of insulin was used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 2, "question": "What substances were used to stimulate platelet activation in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3425422, "edit_id": 3, "question": "By how much did premeal insulin reduce post-meal high blood sugar levels compared to the placebo?", "category": "concept", "label": "comparison"}, {"doc_id": 3441250, "edit_id": 0, "question": "What specific type of colloid was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 1, "question": "What specific type of crystalloid was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3441250, "edit_id": 2, "question": "How was the volume of fluid administered to the patients calculated?", "category": "omission", "label": "procedural"}, {"doc_id": 3441250, "edit_id": 3, "question": "What were the mean nausea scores for the colloid and crystalloid groups?", "category": "omission", "label": "extent"}, {"doc_id": 3441250, "edit_id": 4, "question": "What specific tests were performed on the patients' lungs?", "category": "concept", "label": "procedural"}, {"doc_id": 3441250, "edit_id": 5, "question": "What specific aspects of lung function were reduced in both groups?", "category": "concept", "label": "concept"}, {"doc_id": 3482439, "edit_id": 0, "question": "What was the specific classification of the hip fractures in the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3482439, "edit_id": 1, "question": "How long was the follow-up period in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3482439, "edit_id": 2, "question": "What specific factors were compared in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3482439, "edit_id": 3, "question": "What is the Z-effect phenomenon that was noticed in the group treated with cephalomedullary nails?", "category": "concept", "label": "concept"}, {"doc_id": 3483284, "edit_id": 0, "question": "What roles do ATP and its metabolite adenosine play in the body?", "category": "omission", "label": "concept"}, {"doc_id": 3483284, "edit_id": 1, "question": "How does increased blood flow help muscles during exercise?", "category": "omission", "label": "cause"}, {"doc_id": 3483284, "edit_id": 2, "question": "What specific aspects of muscle performance did the study aim to improve with ATP supplementation?", "category": "concept", "label": "concept"}, {"doc_id": 3483284, "edit_id": 3, "question": "What were the specific results of the study regarding the effects of ATP supplementation on muscle performance?", "category": "concept", "label": "consequence"}, {"doc_id": 3511949, "edit_id": 0, "question": "What was the dosage of the supplementary analgesics given to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 3511949, "edit_id": 1, "question": "How was the decrease in pain measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3511949, "edit_id": 2, "question": "What does the WOMAC test measure?", "category": "concept", "label": "concept"}, {"doc_id": 3511949, "edit_id": 3, "question": "How were the morphine and triamcinolone administered in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 0, "question": "What were the specific outcome measures used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3515338, "edit_id": 1, "question": "How was resource use measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 2, "question": "How was missing data handled in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 3, "question": "What statistical method was used to analyze costs and cost-effectiveness in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3515338, "edit_id": 4, "question": "What type of study was performed alongside the clinical trial?", "category": "concept", "label": "concept"}, {"doc_id": 3515338, "edit_id": 5, "question": "What score on the General Health Questionnaire was used to identify patients with mental health problems?", "category": "concept", "label": "concept"}, {"doc_id": 3515338, "edit_id": 6, "question": "What were the mean total costs for each group in the study?", "category": "concept", "label": "extent"}, {"doc_id": 3564932, "edit_id": 0, "question": "How many women were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3564932, "edit_id": 1, "question": "What test was performed on the women in the outpatient group before they were discharged?", "category": "omission", "label": "procedural"}, {"doc_id": 3564932, "edit_id": 2, "question": "What was the dosage of vaginal PGE2 given to the women in the inpatient group?", "category": "omission", "label": "extent"}, {"doc_id": 3564932, "edit_id": 3, "question": "What is the trial registration number of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3564932, "edit_id": 4, "question": "How long did the women in the outpatient group stay in the hospital before giving birth?", "category": "concept", "label": "extent"}, {"doc_id": 3564932, "edit_id": 5, "question": "How did the outpatient group fare in terms of pain and sleep during cervical preparation?", "category": "concept", "label": "comparison"}, {"doc_id": 3570228, "edit_id": 0, "question": "What were the specific concentrations of remifentanil and sufentanil used in each group?", "category": "omission", "label": "procedural"}, {"doc_id": 3570228, "edit_id": 1, "question": "What specific hormones related to stress were measured in the blood samples?", "category": "omission", "label": "procedural"}, {"doc_id": 3570228, "edit_id": 2, "question": "What does it mean that Group IV had a larger circulation fluctuation control number?", "category": "concept", "label": "concept"}, {"doc_id": 3570228, "edit_id": 3, "question": "What does \"postoperative eye-opening and extubation time\" refer to in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3575357, "edit_id": 0, "question": "What specific questionnaires were used to measure the general state of health and quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 1, "question": "What specific tests were used to measure cardiopulmonary function?", "category": "omission", "label": "procedural"}, {"doc_id": 3575357, "edit_id": 2, "question": "How significant was the improvement in quality of life in men?", "category": "concept", "label": "extent"}, {"doc_id": 3575357, "edit_id": 3, "question": "How significant was the improvement in quality of life in men when comparing between groups?", "category": "concept", "label": "comparison"}, {"doc_id": 3575357, "edit_id": 4, "question": "How significant was the improvement in pulmonary outcomes in men within the experimental group?", "category": "concept", "label": "extent"}, {"doc_id": 3580299, "edit_id": 0, "question": "What was the dosage of loxoprofen sodium given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 1, "question": "How long did the drug administration last after the ESWL procedure?", "category": "omission", "label": "extent"}, {"doc_id": 3580299, "edit_id": 2, "question": "How was the medical trial conducted?", "category": "concept", "label": "procedural"}, {"doc_id": 3580299, "edit_id": 3, "question": "What was the average number of ESWL sessions required for each group?", "category": "concept", "label": "extent"}, {"doc_id": 3580299, "edit_id": 4, "question": "What were the pain severity scores for each group?", "category": "concept", "label": "extent"}, {"doc_id": 3608893, "edit_id": 0, "question": "What were the specific percentages of HbA1c decline in both the portion-controlled diet group and the diabetes self-management education group?", "category": "omission", "label": "extent"}, {"doc_id": 3608893, "edit_id": 1, "question": "What implications do these findings have for the management of obesity in primary care?", "category": "omission", "label": "consequence"}, {"doc_id": 3608893, "edit_id": 2, "question": "What was the range of ages, body weights, and HbA1c levels of the participants?", "category": "concept", "label": "extent"}, {"doc_id": 3608893, "edit_id": 3, "question": "What were the specific percentages of participants in each group who lost at least 5% and 10% of their initial weight?", "category": "concept", "label": "extent"}, {"doc_id": 3620559, "edit_id": 0, "question": "What were the specific sizes of the needles used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3620559, "edit_id": 1, "question": "What factors were used to stratify the outcomes of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3620559, "edit_id": 2, "question": "What type of study was conducted and what were the characteristics of the participants?", "category": "concept", "label": "concept"}, {"doc_id": 3620559, "edit_id": 3, "question": "How significant was the increase in operating time with the thinner needle?", "category": "concept", "label": "comparison"}, {"doc_id": 3628658, "edit_id": 0, "question": "What type of study design was used in this research?", "category": "omission", "label": "concept"}, {"doc_id": 3628658, "edit_id": 1, "question": "How many patients were enrolled in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3628658, "edit_id": 2, "question": "What specific measures were used to assess the time it took for the fracture to heal and the overall hip health after surgery?", "category": "concept", "label": "procedural"}, {"doc_id": 3628658, "edit_id": 3, "question": "What specific complications were observed in each group?", "category": "concept", "label": "procedural"}, {"doc_id": 3630066, "edit_id": 0, "question": "Have there been any reports of benefits from CO2 inhalation in patients with facial pain?", "category": "omission", "label": "verification"}, {"doc_id": 3630066, "edit_id": 1, "question": "How long did the participants receive continuous nasal insufflation of CO2 or placebo?", "category": "omission", "label": "extent"}, {"doc_id": 3630066, "edit_id": 2, "question": "How did the effects of CO2 on experimental trigeminal pain in this study compare to previous animal studies?", "category": "concept", "label": "comparison"}, {"doc_id": 3630066, "edit_id": 3, "question": "Besides the 5.3% reduction in pain ratings, were there any other significant results in the first experiment?", "category": "concept", "label": "disjunction"}, {"doc_id": 3656551, "edit_id": 0, "question": "Was the study conducted in multiple locations and did it consider the age of the children?", "category": "omission", "label": "verification"}, {"doc_id": 3656551, "edit_id": 1, "question": "How many children were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3656551, "edit_id": 2, "question": "Did the vaccine meet the regulatory criteria for immunogenicity for all virus strains and doses for both age groups?", "category": "concept", "label": "verification"}, {"doc_id": 3656551, "edit_id": 3, "question": "Was the improvement in immune responses with the higher dose statistically significant and were the reactogenicity and safety of the 2 doses significantly different?", "category": "concept", "label": "comparison"}, {"doc_id": 3658388, "edit_id": 0, "question": "Is this trial registered with any official database?", "category": "omission", "label": "verification"}, {"doc_id": 3658388, "edit_id": 1, "question": "How was the study designed to ensure unbiased results?", "category": "concept", "label": "procedural"}, {"doc_id": 3658388, "edit_id": 2, "question": "What specific tests were used to measure the participants' hearing abilities?", "category": "concept", "label": "procedural"}, {"doc_id": 3659039, "edit_id": 0, "question": "What happens to the levels of omega-6 fatty acids when omega-3 fatty acids are increased?", "category": "omission", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 1, "question": "What kind of treatment did the patients receive?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 2, "question": "In what components of the blood were the fatty acids measured?", "category": "omission", "label": "concept"}, {"doc_id": 3659039, "edit_id": 3, "question": "Which specific fatty acids increased and decreased in the treatment group?", "category": "concept", "label": "consequence"}, {"doc_id": 3659039, "edit_id": 4, "question": "Which specific fatty acids returned to baseline levels after the washout period, and which remained elevated?", "category": "concept", "label": "consequence"}, {"doc_id": 3671234, "edit_id": 0, "question": "What was the health status of the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 1, "question": "What specific anesthetic was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3671234, "edit_id": 2, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 3671234, "edit_id": 3, "question": "What form and dosage of midazolam was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3671234, "edit_id": 4, "question": "What is the medical term for nausea and vomiting after surgery?", "category": "concept", "label": "concept"}, {"doc_id": 3681405, "edit_id": 0, "question": "What were the endpoints of the study?", "category": "omission", "label": "concept"}, {"doc_id": 3681405, "edit_id": 1, "question": "Was there a significant survival difference found in any specific stage of NSCLC?", "category": "omission", "label": "verification"}, {"doc_id": 3681405, "edit_id": 2, "question": "What was the exact difference in median survival time between the group that received preoperative chemotherapy and the group that only had surgery?", "category": "concept", "label": "extent"}, {"doc_id": 3681405, "edit_id": 3, "question": "What was the hazard ratio and confidence interval for the difference in progression-free survival in stage I NSCLC patients?", "category": "concept", "label": "extent"}, {"doc_id": 3687098, "edit_id": 0, "question": "What type of studies were included in the analysis?", "category": "omission", "label": "concept"}, {"doc_id": 3687098, "edit_id": 1, "question": "How was sitagliptin assessed in the studies?", "category": "omission", "label": "procedural"}, {"doc_id": 3687098, "edit_id": 2, "question": "How did the researchers compare the rate of side effects between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 3687098, "edit_id": 3, "question": "How did the overall incidence rates of adverse events and drug-related adverse events compare between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 3691658, "edit_id": 0, "question": "What were the specific doses of Vitamin D3 given to the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 1, "question": "What serum levels were measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 2, "question": "What other factors were documented in the study besides relapses, adverse events, and quality of life?", "category": "omission", "label": "concept"}, {"doc_id": 3691658, "edit_id": 3, "question": "Which hormone levels decreased in the high dose group?", "category": "concept", "label": "consequence"}, {"doc_id": 3691658, "edit_id": 4, "question": "How did the high dose group respond in terms of IL-17 levels?", "category": "concept", "label": "consequence"}, {"doc_id": 3691658, "edit_id": 5, "question": "Were there any significant changes in serum IL-10 and IFN\u03b3 levels?", "category": "concept", "label": "verification"}, {"doc_id": 3730064, "edit_id": 0, "question": "What were the specific dosages of the bevacizumab and ranibizumab injections and how were they administered?", "category": "omission", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 1, "question": "What were the specific causes of the unusual blood vessel growth in the cornea in the patients?", "category": "omission", "label": "cause"}, {"doc_id": 3730064, "edit_id": 2, "question": "How were the changes in the unusual blood vessels in the cornea measured?", "category": "concept", "label": "procedural"}, {"doc_id": 3730064, "edit_id": 3, "question": "What were the specific percentages of decrease in the unusual blood vessels in the cornea in the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 3751568, "edit_id": 0, "question": "Was there a period without treatment before the exercise program started?", "category": "omission", "label": "verification"}, {"doc_id": 3751568, "edit_id": 1, "question": "How was the randomisation of the children into the two groups done?", "category": "omission", "label": "procedural"}, {"doc_id": 3751568, "edit_id": 2, "question": "How significant were the differences in parent-reported overall psychosocial health, self-esteem, mental health, and behaviour between the two groups?", "category": "omission", "label": "extent"}, {"doc_id": 3751568, "edit_id": 3, "question": "What was the trial registration number for this study?", "category": "omission", "label": "concept"}, {"doc_id": 3751568, "edit_id": 4, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 3751568, "edit_id": 5, "question": "How significant was the reduction in knee pain and what was the confidence interval?", "category": "concept", "label": "extent"}, {"doc_id": 3751568, "edit_id": 6, "question": "How significant was the parent-reported overall physical health favouring exercising only to neutral?", "category": "concept", "label": "extent"}, {"doc_id": 3780629, "edit_id": 0, "question": "What type of computerized exercises were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 1, "question": "What type of online therapy was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 2, "question": "What specific type of computerized cognitive-bias modification (CBM) protocol was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3780629, "edit_id": 3, "question": "What statistical method was used to analyze the data in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3780629, "edit_id": 4, "question": "What was the specific diagnosis of the participants in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3780629, "edit_id": 5, "question": "What was the significance of the improvements observed in the participants following the computerized exercises and the combined intervention?", "category": "concept", "label": "extent"}, {"doc_id": 3781573, "edit_id": 0, "question": "What was the name of the trial that this study was based on?", "category": "omission", "label": "concept"}, {"doc_id": 3781573, "edit_id": 1, "question": "How was diabetic peripheral neuropathy defined in this study?", "category": "omission", "label": "concept"}, {"doc_id": 3781573, "edit_id": 2, "question": "What specific statistical methods were used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 3781573, "edit_id": 3, "question": "What were the specific 4-year cumulative incidence rates of DPN in the IS and IP groups?", "category": "concept", "label": "extent"}, {"doc_id": 3781573, "edit_id": 4, "question": "What was the specific benefit of the IS strategy for men?", "category": "concept", "label": "concept"}, {"doc_id": 3798949, "edit_id": 0, "question": "What were the phases of the clinical trials conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 3798949, "edit_id": 1, "question": "How was the treatment cost difference calculated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3798949, "edit_id": 2, "question": "How much money was saved in each year of the study?", "category": "omission", "label": "extent"}, {"doc_id": 3798949, "edit_id": 3, "question": "How many of the trials were academic and how many were commercial?", "category": "concept", "label": "extent"}, {"doc_id": 3798949, "edit_id": 4, "question": "What was the range of costs for the non-commercial and commercial trials?", "category": "concept", "label": "extent"}, {"doc_id": 3814649, "edit_id": 0, "question": "What were the components and their concentrations in the first freezing mixture used in the experiments?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 1, "question": "What were the components and their concentrations in the second freezing mixture used in the experiments?", "category": "omission", "label": "concept"}, {"doc_id": 3814649, "edit_id": 2, "question": "What was the specific process for the fast-freezing and quick warming of the COCs in the fourth group?", "category": "omission", "label": "procedural"}, {"doc_id": 3814649, "edit_id": 3, "question": "What specific stages of growth and development were measured in the experiments?", "category": "concept", "label": "concept"}, {"doc_id": 3814649, "edit_id": 4, "question": "How significant was the difference in growth and development rates between the group that underwent fast-freezing and quick warming and the other groups?", "category": "concept", "label": "extent"}, {"doc_id": 3816909, "edit_id": 0, "question": "What was the average age and BMI of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3816909, "edit_id": 1, "question": "What were the specific genetic variants near IRS1 that were studied?", "category": "omission", "label": "concept"}, {"doc_id": 3816909, "edit_id": 2, "question": "What does it mean that the diets had a reduction of 750 daily calories?", "category": "concept", "label": "concept"}, {"doc_id": 3816909, "edit_id": 3, "question": "What were the odds ratios for the 2-year reversion of MetS among the carriers and non-carriers of the rs1522813 A-allele?", "category": "concept", "label": "extent"}, {"doc_id": 3821103, "edit_id": 0, "question": "What type of study was conducted to compare the efficacy of morphine and tramadol?", "category": "omission", "label": "concept"}, {"doc_id": 3821103, "edit_id": 1, "question": "How was the pain evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 2, "question": "At what specific times were the post-operative VRS scores significantly decreased?", "category": "omission", "label": "extent"}, {"doc_id": 3821103, "edit_id": 3, "question": "What was the dosage of morphine and tramadol administered to the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 3821103, "edit_id": 4, "question": "How significant was the difference in pain experienced by the tramadol-treated group?", "category": "concept", "label": "extent"}, {"doc_id": 3821103, "edit_id": 5, "question": "When was the maximum effect of the pain relievers observed?", "category": "concept", "label": "extent"}, {"doc_id": 3877023, "edit_id": 0, "question": "Were the patients in this study part of a larger group?", "category": "omission", "label": "verification"}, {"doc_id": 3877023, "edit_id": 1, "question": "How long did the scans take on average for each method?", "category": "omission", "label": "extent"}, {"doc_id": 3877023, "edit_id": 2, "question": "Were the patients selected for the study in a consecutive manner?", "category": "concept", "label": "verification"}, {"doc_id": 3877023, "edit_id": 3, "question": "What specific parameters were used to assess the quality of the images?", "category": "concept", "label": "procedural"}, {"doc_id": 3877023, "edit_id": 4, "question": "How did the contrast-to-noise ratios (CNR) compare between the two methods?", "category": "concept", "label": "comparison"}, {"doc_id": 3892495, "edit_id": 0, "question": "How much glucose was given to the subjects in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3892495, "edit_id": 1, "question": "What was the intensity of the treadmill exercise in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3892495, "edit_id": 2, "question": "What exactly was compared between the subjects who had the glucose drink and those who had water?", "category": "concept", "label": "comparison"}, {"doc_id": 3892495, "edit_id": 3, "question": "What exactly was compared between the subjects who had the glucose drink and those who had water in terms of free fatty acids?", "category": "concept", "label": "comparison"}, {"doc_id": 3892495, "edit_id": 4, "question": "What exactly was compared between the subjects who had the glucose drink and those who had water in terms of glucose and insulin?", "category": "concept", "label": "comparison"}, {"doc_id": 3893439, "edit_id": 0, "question": "What breed of rats were used in the study?", "category": "omission", "label": "example"}, {"doc_id": 3893439, "edit_id": 1, "question": "What specific cognitive tests were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 2, "question": "What specific proteins were measured to assess brain energy homeostasis?", "category": "omission", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 3, "question": "What specific type of brain injury model was used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 3893439, "edit_id": 4, "question": "What specific inflammatory and anti-inflammatory proteins were measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3893439, "edit_id": 5, "question": "What was the effect of environmental enrichment on the pAMPK/AMPK ratio and uMtCK levels after a minor brain injury?", "category": "concept", "label": "consequence"}, {"doc_id": 3917487, "edit_id": 0, "question": "What were the average age, weight, and height of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3917487, "edit_id": 1, "question": "What specific tests were used to measure the participants' performance and oxygen usage during exercise?", "category": "omission", "label": "procedural"}, {"doc_id": 3917487, "edit_id": 2, "question": "Was the trial registered and if so, what was the registration ID?", "category": "omission", "label": "verification"}, {"doc_id": 3917487, "edit_id": 3, "question": "What were the average changes in the records of the probiotic yogurt group and the regular yogurt group?", "category": "concept", "label": "extent"}, {"doc_id": 3917487, "edit_id": 4, "question": "How long did the probiotic yogurt group and the regular yogurt group experience difficulty breathing and ear pain?", "category": "concept", "label": "extent"}, {"doc_id": 3917487, "edit_id": 5, "question": "What was the average number of episodes of respiratory infection in the probiotic yogurt group and the regular yogurt group?", "category": "concept", "label": "extent"}, {"doc_id": 3921228, "edit_id": 0, "question": "What part of the brain was used for the control group in the study?", "category": "omission", "label": "concept"}, {"doc_id": 3921228, "edit_id": 1, "question": "Was there any part of the experiment where participants were not given neurofeedback information?", "category": "omission", "label": "verification"}, {"doc_id": 3921228, "edit_id": 2, "question": "How many participants were in the experimental group?", "category": "concept", "label": "extent"}, {"doc_id": 3921228, "edit_id": 3, "question": "How were changes in anxiety and happiness measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 3921228, "edit_id": 4, "question": "In which areas of the brain was increased activity observed during the transfer run?", "category": "concept", "label": "concept"}, {"doc_id": 3926947, "edit_id": 0, "question": "What specific follow-up form did the parents fill out?", "category": "omission", "label": "procedural"}, {"doc_id": 3926947, "edit_id": 1, "question": "When was the follow-up conducted after the treatment?", "category": "omission", "label": "extent"}, {"doc_id": 3926947, "edit_id": 2, "question": "Was the difference in response rates between the phone and mail groups statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 3926947, "edit_id": 3, "question": "Was the difference in the need for reminders between the phone and mail groups statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 3932017, "edit_id": 0, "question": "What specific techniques were used to study the arterial changes?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 1, "question": "What specific measures and instrument were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3932017, "edit_id": 2, "question": "What else was analyzed in the study besides the changes in the carotid artery?", "category": "omission", "label": "concept"}, {"doc_id": 3932017, "edit_id": 3, "question": "What were the specific measures and their values for the speed at which the pulse travelled, the stiffness of the artery, and the artery's flexibility?", "category": "concept", "label": "extent"}, {"doc_id": 3932017, "edit_id": 4, "question": "What were the specific measures and their values for how the arteries moved and adjusted?", "category": "concept", "label": "extent"}, {"doc_id": 3943081, "edit_id": 0, "question": "How often did the test group receive chest physiotherapy?", "category": "omission", "label": "extent"}, {"doc_id": 3943081, "edit_id": 1, "question": "What was the main difference in treatment between the test group and the comparison group?", "category": "concept", "label": "comparison"}, {"doc_id": 3943081, "edit_id": 2, "question": "What kind of position changes can help reduce the rate of lung collapse in pediatric patients?", "category": "concept", "label": "example"}, {"doc_id": 3953523, "edit_id": 0, "question": "What specific tools were used to measure the outcomes in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3953523, "edit_id": 1, "question": "What is the specific term used to describe the version of aceclofenac that is released slowly over time?", "category": "concept", "label": "concept"}, {"doc_id": 3953523, "edit_id": 2, "question": "What is the specific term used to describe the version of aceclofenac that is released immediately?", "category": "concept", "label": "concept"}, {"doc_id": 3953523, "edit_id": 3, "question": "What specific measures were used to evaluate the safety of the medication?", "category": "concept", "label": "procedural"}, {"doc_id": 3984795, "edit_id": 0, "question": "What was the Body Mass Index (BMI) of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 1, "question": "How many participants were there in each group?", "category": "omission", "label": "extent"}, {"doc_id": 3984795, "edit_id": 2, "question": "What specific types of cholesterol were affected by the probiotic VSL#3?", "category": "concept", "label": "concept"}, {"doc_id": 3984795, "edit_id": 3, "question": "What specific marker of inflammation was reduced by the probiotic VSL#3?", "category": "concept", "label": "concept"}, {"doc_id": 3984795, "edit_id": 4, "question": "What specific effects did Omega-3 have on insulin sensitivity and inflammation?", "category": "concept", "label": "consequence"}, {"doc_id": 3990364, "edit_id": 0, "question": "What device was used to measure the spinal range of motion in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 3990364, "edit_id": 1, "question": "Was the improvement in the lower back region statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 3990364, "edit_id": 2, "question": "Were the improvements in forward bending, back-and-hips bending, and chest area bending statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 3990364, "edit_id": 3, "question": "Who is the training protocol suitable for?", "category": "concept", "label": "concept"}, {"doc_id": 4006208, "edit_id": 0, "question": "What was the concentration of chlorhexidine gluconate in the mouthwash used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4006208, "edit_id": 1, "question": "What do the Gingival index (GI) and Plaque index (PI) measure?", "category": "concept", "label": "concept"}, {"doc_id": 4006208, "edit_id": 2, "question": "How often were the subjects asked to use their assigned mouthwash?", "category": "concept", "label": "extent"}, {"doc_id": 4006208, "edit_id": 3, "question": "What does it mean when the study says there was no statistically significant difference between the Aloe vera and chlorhexidine groups?", "category": "concept", "label": "concept"}, {"doc_id": 4015738, "edit_id": 0, "question": "When were the measurements taken during and after the surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 1, "question": "What types of fluids were administered in the balanced and unbalanced solutions?", "category": "omission", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 2, "question": "What specific variables were measured during and after the surgery?", "category": "concept", "label": "procedural"}, {"doc_id": 4015738, "edit_id": 3, "question": "What specific proteins and kidney damage marker were found in the groups that received balanced and unbalanced fluids?", "category": "concept", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 0, "question": "What statistical methods were used to compare the two groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 1, "question": "Was there any difference in the pain scores between the two groups in the first 48 hours after surgery?", "category": "omission", "label": "comparison"}, {"doc_id": 4018698, "edit_id": 2, "question": "What was the exact dosage and type of anesthetic used in each group?", "category": "concept", "label": "procedural"}, {"doc_id": 4018698, "edit_id": 3, "question": "What specific type of blood pressure was lower in the group that received the drug into the space around the spinal column?", "category": "concept", "label": "comparison"}, {"doc_id": 4065461, "edit_id": 0, "question": "What type of study was conducted to investigate the effects of the drug combinations on infants with bronchiolitis?", "category": "omission", "label": "concept"}, {"doc_id": 4065461, "edit_id": 1, "question": "What were the primary and secondary outcomes that the study was measuring?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 2, "question": "How were the infants divided into groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4065461, "edit_id": 3, "question": "Which treatment resulted in a significant change in heart rate over time?", "category": "concept", "label": "comparison"}, {"doc_id": 4065461, "edit_id": 4, "question": "For which specific group of infants does the study suggest that corticosteroids are not beneficial in managing bronchiolitis?", "category": "concept", "label": "disjunction"}, {"doc_id": 4069047, "edit_id": 0, "question": "What specific tools were used to measure cognitive functioning, sleep quality, and safety parameters in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 1, "question": "How was the study designed and what was the treatment plan for the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4069047, "edit_id": 2, "question": "How much better was the cognitive performance of the patients treated with prolonged-release melatonin compared to those treated with placebo?", "category": "concept", "label": "comparison"}, {"doc_id": 4069047, "edit_id": 3, "question": "How much better was the sleep efficiency of the patients treated with prolonged-release melatonin compared to those treated with placebo?", "category": "concept", "label": "comparison"}, {"doc_id": 4078065, "edit_id": 0, "question": "On what type of cells was the effect of citrulline on ABCA1 and ABCG1 levels studied?", "category": "omission", "label": "concept"}, {"doc_id": 4078065, "edit_id": 1, "question": "What type of cells were used to observe the effect of citrulline consumption in humans and how were they treated?", "category": "omission", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 2, "question": "In what settings was the effect of citrulline on ABCA1 and ABCG1 expressions and cholesterol efflux studied?", "category": "concept", "label": "procedural"}, {"doc_id": 4078065, "edit_id": 3, "question": "How much citrulline did the volunteers consume daily?", "category": "concept", "label": "extent"}, {"doc_id": 4092926, "edit_id": 0, "question": "What were the characteristics of the goats used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4092926, "edit_id": 1, "question": "What happened to the goats at the end of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4092926, "edit_id": 2, "question": "What do the percentages in the different diets represent?", "category": "concept", "label": "concept"}, {"doc_id": 4092926, "edit_id": 3, "question": "What were the specific measurements and percentages of the evaluated traits?", "category": "concept", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 0, "question": "What were the specific statistical results of the study comparing the top 30% of 3'AmNic-rEPA recipients to the placebo recipients?", "category": "omission", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 1, "question": "How was the study designed to ensure its validity?", "category": "concept", "label": "procedural"}, {"doc_id": 4106715, "edit_id": 2, "question": "What is the active ingredient in the NicVAX\u00ae vaccine?", "category": "concept", "label": "concept"}, {"doc_id": 4115605, "edit_id": 0, "question": "What was the dosage range of droxidopa given to the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 1, "question": "How many patients were part of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 2, "question": "How much did the standing and supine systolic blood pressure increase in patients who were given droxidopa?", "category": "omission", "label": "extent"}, {"doc_id": 4115605, "edit_id": 3, "question": "What specific questionnaire was used to track the patients' progress in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4115605, "edit_id": 4, "question": "What is the classification of evidence provided by the study?", "category": "concept", "label": "concept"}, {"doc_id": 4121500, "edit_id": 0, "question": "What was the physical status of the patients according to the American Society of Anesthesiologists?", "category": "omission", "label": "concept"}, {"doc_id": 4121500, "edit_id": 1, "question": "What were the specific doses given to each group?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 2, "question": "What specific measurements were taken and when were they taken?", "category": "omission", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 3, "question": "What other factors were monitored during the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4121500, "edit_id": 4, "question": "Was there any significant difference in the Ramsay scores between the two groups?", "category": "concept", "label": "verification"}, {"doc_id": 4140238, "edit_id": 0, "question": "What phase were the clinical trials in and how many centers were involved? What model was used for allergic conjunctivitis?", "category": "omission", "label": "concept"}, {"doc_id": 4140238, "edit_id": 1, "question": "At what specific time intervals were changes in eye itching and redness assessed?", "category": "omission", "label": "procedural"}, {"doc_id": 4140238, "edit_id": 2, "question": "What were the secondary measurements in the study and how were they judged?", "category": "concept", "label": "procedural"}, {"doc_id": 4140238, "edit_id": 3, "question": "What was the clinical significance of the onset and 8-hour persistence of action of the antihistamine eye drop?", "category": "concept", "label": "consequence"}, {"doc_id": 4166055, "edit_id": 0, "question": "What type of surgery were the patients scheduled for?", "category": "omission", "label": "concept"}, {"doc_id": 4166055, "edit_id": 1, "question": "What was the specific dosage of hypertonic and normal saline given to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4166055, "edit_id": 2, "question": "When was the hypertonic saline infused?", "category": "omission", "label": "procedural"}, {"doc_id": 4166055, "edit_id": 3, "question": "What were the specific effects of hypertonic saline on MAP and heart rate?", "category": "concept", "label": "consequence"}, {"doc_id": 4166058, "edit_id": 0, "question": "What are the specific physical criteria required to administer oxygen to newborns through a nasal cannula?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 1, "question": "What are the capabilities of a nasal cannula in administering therapy?", "category": "omission", "label": "concept"}, {"doc_id": 4166058, "edit_id": 2, "question": "What type of study was conducted and what were the specific conditions of the babies involved?", "category": "concept", "label": "concept"}, {"doc_id": 4166058, "edit_id": 3, "question": "How were the patients grouped and what treatment did they receive?", "category": "concept", "label": "procedural"}, {"doc_id": 4171519, "edit_id": 0, "question": "What breed of rats were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4171519, "edit_id": 1, "question": "Why was the femoral toughness greater in raloxifene-treated rats?", "category": "omission", "label": "cause"}, {"doc_id": 4171519, "edit_id": 2, "question": "What type of diet were the rats fed?", "category": "concept", "label": "concept"}, {"doc_id": 4171519, "edit_id": 3, "question": "What type of hemoglobin was measured at the start and end of the experiments?", "category": "concept", "label": "concept"}, {"doc_id": 4171519, "edit_id": 4, "question": "Which bones were tested after the rats were killed and what tests were performed?", "category": "concept", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 0, "question": "How many drug stores were selected for the study and how many of them received text message reminders?", "category": "omission", "label": "extent"}, {"doc_id": 4183415, "edit_id": 1, "question": "How did the researchers collect information about the patients' adherence to their medication schedules?", "category": "omission", "label": "procedural"}, {"doc_id": 4183415, "edit_id": 2, "question": "What were the specific percentages of patients who completed all their doses and those who took each dose at the correct time in both the intervention and control groups?", "category": "concept", "label": "extent"}, {"doc_id": 4202567, "edit_id": 0, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4202567, "edit_id": 1, "question": "What specific task was used to test the participants' working memory?", "category": "omission", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 2, "question": "What statistical analysis was used and what were the specific results?", "category": "concept", "label": "procedural"}, {"doc_id": 4202567, "edit_id": 3, "question": "What was the effect of the inverse polarity on the 2-back working memory task?", "category": "concept", "label": "consequence"}, {"doc_id": 4202567, "edit_id": 4, "question": "What needs to be studied further in relation to tDCS and working memory?", "category": "concept", "label": "concept"}, {"doc_id": 4231047, "edit_id": 0, "question": "What type of radiotherapy was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4231047, "edit_id": 1, "question": "How was the minimal threshold dose quantified in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4231047, "edit_id": 2, "question": "Why was the study stopped early?", "category": "concept", "label": "cause"}, {"doc_id": 4231047, "edit_id": 3, "question": "How effective was the combination treatment in reducing liver injury after radiation treatment?", "category": "concept", "label": "extent"}, {"doc_id": 4231047, "edit_id": 4, "question": "What does the comparable incidences of liver injury in the treatment and control groups at 12 weeks suggest about the effectiveness of the combination treatment?", "category": "concept", "label": "comparison"}, {"doc_id": 4236282, "edit_id": 0, "question": "How was the quality of the implementation of the interventions in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4236282, "edit_id": 1, "question": "What type of study was conducted to test the effectiveness of the interventions?", "category": "omission", "label": "concept"}, {"doc_id": 4236282, "edit_id": 2, "question": "Who were the participants in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4236282, "edit_id": 3, "question": "Did the NPC group show significant improvements compared to both the UC and MIC groups?", "category": "concept", "label": "verification"}, {"doc_id": 4236282, "edit_id": 4, "question": "Were the weight loss results maintained at the 3-month follow-up?", "category": "concept", "label": "verification"}, {"doc_id": 4260384, "edit_id": 0, "question": "What type of gum recession cases were treated in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 1, "question": "Besides the depth and width of the gum recession, what other factors were measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4260384, "edit_id": 2, "question": "What specific improvements were observed with the combination of the surgical technique and the collagen membrane in treating gum recession?", "category": "concept", "label": "consequence"}, {"doc_id": 4262215, "edit_id": 0, "question": "What did the usual nursing care for the control group involve?", "category": "omission", "label": "procedural"}, {"doc_id": 4262215, "edit_id": 1, "question": "Was there a statistical relationship between the patients' suicidal thoughts and their physical and mental abilities?", "category": "omission", "label": "verification"}, {"doc_id": 4262215, "edit_id": 2, "question": "What were the exact names of the tools used to measure suicidal thoughts and physical and mental abilities in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4262215, "edit_id": 3, "question": "What were the exact factors that were measured in the study before the treatment?", "category": "concept", "label": "concept"}, {"doc_id": 4283690, "edit_id": 0, "question": "What was the name and registration number of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4283690, "edit_id": 1, "question": "What specific survey was used to measure the impact of PsA on work and household productivity, and participation in social activities?", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 2, "question": "What statistical method was used to compare the survey responses between the treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 4283690, "edit_id": 3, "question": "What were the exact percentages of employed patients in each group at the start of the study?", "category": "concept", "label": "extent"}, {"doc_id": 4283690, "edit_id": 4, "question": "How many fewer days of absenteeism and presenteeism did placebo patients report by week 24?", "category": "concept", "label": "extent"}, {"doc_id": 4283690, "edit_id": 5, "question": "How many household work days did placebo patients gain per month by week 24?", "category": "concept", "label": "extent"}, {"doc_id": 4302388, "edit_id": 0, "question": "At what stages of pregnancy were the selenium levels and related measurements taken?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 1, "question": "What was the name of the study from which the samples originated?", "category": "omission", "label": "concept"}, {"doc_id": 4302388, "edit_id": 2, "question": "How did the selenium levels of UK pregnant women compare to those of other populations?", "category": "concept", "label": "comparison"}, {"doc_id": 4302388, "edit_id": 3, "question": "How did maternal age, education, and social class affect selenium status?", "category": "concept", "label": "comparison"}, {"doc_id": 4302388, "edit_id": 4, "question": "How much did selenium supplementation reduce the risk of developing PE/PIH?", "category": "concept", "label": "extent"}, {"doc_id": 4313493, "edit_id": 0, "question": "How many drops per milliliter were there for each drug?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 1, "question": "What were the daily and yearly costs of each drug?", "category": "omission", "label": "extent"}, {"doc_id": 4313493, "edit_id": 2, "question": "How much did each drug reduce intraocular pressure?", "category": "concept", "label": "extent"}, {"doc_id": 4313493, "edit_id": 3, "question": "What was the cost-effectiveness ratio for each drug?", "category": "concept", "label": "extent"}, {"doc_id": 4323432, "edit_id": 0, "question": "What type of study was conducted to compare the effects of phloroglucin and cimetropium bromide?", "category": "omission", "label": "concept"}, {"doc_id": 4323432, "edit_id": 1, "question": "How many patients participated in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4323432, "edit_id": 2, "question": "Where in the digestive system did the researchers assess the number and intensity of muscle contractions?", "category": "concept", "label": "procedural"}, {"doc_id": 4323432, "edit_id": 3, "question": "What was the difference in the number of gastric peristalsis events between the group that took phloroglucin and the group that took cimetropium bromide?", "category": "concept", "label": "comparison"}, {"doc_id": 4329963, "edit_id": 0, "question": "What type of drug users were involved in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 1, "question": "Where was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 4329963, "edit_id": 2, "question": "How many subjects were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4329963, "edit_id": 3, "question": "What models were used for the educational intervention in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4329963, "edit_id": 4, "question": "What tools were used to gather data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4329963, "edit_id": 5, "question": "What statistical tests were used to analyze the data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 0, "question": "What specific scale was used to measure symptoms of depression in the caregivers?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 1, "question": "What specific scale was used to measure symptoms of anxiety in the caregivers?", "category": "omission", "label": "procedural"}, {"doc_id": 4334515, "edit_id": 2, "question": "What were the effect sizes for symptoms of anxiety and depression in the caregivers?", "category": "omission", "label": "consequence"}, {"doc_id": 4334515, "edit_id": 3, "question": "What type of study was conducted to assess the effectiveness of the 'Mastery over Dementia' program?", "category": "concept", "label": "concept"}, {"doc_id": 4334515, "edit_id": 4, "question": "What was the intervention received by the second group of caregivers?", "category": "concept", "label": "concept"}, {"doc_id": 4334515, "edit_id": 5, "question": "What type of analysis was carried out on the data collected from the caregivers?", "category": "concept", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 0, "question": "What role do reinforcement signals in the striatum play in drug intake?", "category": "omission", "label": "concept"}, {"doc_id": 4354356, "edit_id": 1, "question": "What specific methods did the researchers use to compare the resting-state functional connectivity strengths?", "category": "omission", "label": "procedural"}, {"doc_id": 4354356, "edit_id": 2, "question": "In which specific network did heroin increase the connectivity of the left putamen?", "category": "concept", "label": "concept"}, {"doc_id": 4354356, "edit_id": 3, "question": "Which part of the brain showed increased activity in healthy individuals compared to the patients when they took placebo?", "category": "concept", "label": "comparison"}, {"doc_id": 4355443, "edit_id": 0, "question": "What was the initial tumor load of the patients in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 1, "question": "What were the BCLC stages of the patients in each group?", "category": "omission", "label": "concept"}, {"doc_id": 4355443, "edit_id": 2, "question": "What were the specific causes of death in each group?", "category": "omission", "label": "cause"}, {"doc_id": 4355443, "edit_id": 3, "question": "Were the differences in progression-free survival, time to progression, and overall survival between the two groups statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 4355443, "edit_id": 4, "question": "What was the trade-off in the SIRT group between the rate of tumor progression and the incidence of liver failure?", "category": "concept", "label": "comparison"}, {"doc_id": 4358417, "edit_id": 0, "question": "Did the participants change their diet during the study?", "category": "omission", "label": "verification"}, {"doc_id": 4358417, "edit_id": 1, "question": "How did the changes in the rosehip group compare to those in the placebo group?", "category": "omission", "label": "comparison"}, {"doc_id": 4358417, "edit_id": 2, "question": "What was the design of the study and what was the BMI range of the subjects?", "category": "concept", "label": "concept"}, {"doc_id": 4358417, "edit_id": 3, "question": "How did the body fat percentage in the rosehip group change compared to the placebo group and their baseline level?", "category": "concept", "label": "comparison"}, {"doc_id": 4360612, "edit_id": 0, "question": "How did the study define success rates and what statistical method was used to compare them?", "category": "omission", "label": "procedural"}, {"doc_id": 4360612, "edit_id": 1, "question": "What were the average pain and disability scores of the subjects at the start of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4360612, "edit_id": 2, "question": "What type of surgery was performed on the subjects in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4360612, "edit_id": 3, "question": "What measures were used to assess the subjects' pain and disability?", "category": "concept", "label": "procedural"}, {"doc_id": 4360612, "edit_id": 4, "question": "What was the level of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4382580, "edit_id": 0, "question": "How did the researchers ensure that the participants were willingly participating in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4382580, "edit_id": 1, "question": "What specific tests and methods were used to evaluate the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4382580, "edit_id": 2, "question": "What was the age range of the participants in each group?", "category": "omission", "label": "extent"}, {"doc_id": 4382580, "edit_id": 3, "question": "Did one type of therapy show any advantages over the other?", "category": "concept", "label": "comparison"}, {"doc_id": 4391192, "edit_id": 0, "question": "How was sleep quality measured in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 1, "question": "How many patients were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4391192, "edit_id": 2, "question": "What was the registration number of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4391192, "edit_id": 3, "question": "How were the patients assigned to the different groups in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4391192, "edit_id": 4, "question": "Were there any differences in how easily patients could fall asleep again after waking up during the night between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4398332, "edit_id": 0, "question": "How many volunteers participated in the study, what were the selection criteria, and what doses of THC and CBD were administered?", "category": "omission", "label": "extent"}, {"doc_id": 4398332, "edit_id": 1, "question": "What specific emotions were part of the facial affect recognition task and how did their intensity vary?", "category": "omission", "label": "concept"}, {"doc_id": 4398332, "edit_id": 2, "question": "At what intensity of emotions did CBD improve recognition and THC impair recognition?", "category": "concept", "label": "comparison"}, {"doc_id": 4398332, "edit_id": 3, "question": "How was the feeling of being 'stoned' measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4435702, "edit_id": 0, "question": "What exactly is VM202?", "category": "omission", "label": "concept"}, {"doc_id": 4435702, "edit_id": 1, "question": "What other secondary outcomes were measured in the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4435702, "edit_id": 2, "question": "Which group of patients had the largest reductions in pain?", "category": "omission", "label": "comparison"}, {"doc_id": 4435702, "edit_id": 3, "question": "What type of study design was used in this research?", "category": "concept", "label": "concept"}, {"doc_id": 4435702, "edit_id": 4, "question": "How long did the relief from symptoms and improvement in quality of life last after the two days of treatment?", "category": "concept", "label": "extent"}, {"doc_id": 4439020, "edit_id": 0, "question": "What type of brain surgery was performed on the patients and in what position?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 1, "question": "What scale was used to measure the alertness of the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 2, "question": "What is the registration number of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4439020, "edit_id": 3, "question": "Where in the brain did the air build-up occur?", "category": "concept", "label": "concept"}, {"doc_id": 4439020, "edit_id": 4, "question": "What was the concentration of the oxygen given to the patients and how was it administered?", "category": "concept", "label": "procedural"}, {"doc_id": 4439020, "edit_id": 5, "question": "What test was used to measure the attention levels of the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 0, "question": "How many women were in each group of the study?", "category": "omission", "label": "extent"}, {"doc_id": 4450858, "edit_id": 1, "question": "When was feedback collected from the women and the healthcare professionals?", "category": "omission", "label": "procedural"}, {"doc_id": 4450858, "edit_id": 2, "question": "What was the registration number of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4450858, "edit_id": 3, "question": "What was the risk difference and the confidence interval for the need of oxytocin in the outpatient group?", "category": "concept", "label": "extent"}, {"doc_id": 4450858, "edit_id": 4, "question": "How many healthcare professionals agreed that they are more comfortable in sending home a woman with a catheter than prostaglandins?", "category": "concept", "label": "extent"}, {"doc_id": 4472927, "edit_id": 0, "question": "How were the serum levels of the substances measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4472927, "edit_id": 1, "question": "Were there any similarities among the groups in terms of age, serum H. pylori CagA levels, mean drinking age, and mean daily alcohol consumption?", "category": "omission", "label": "comparison"}, {"doc_id": 4472927, "edit_id": 2, "question": "How significant were the differences in serum IL-10 and E-selectin levels between the groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4472927, "edit_id": 3, "question": "Which substances that signify cell damage were measured and how did their levels compare among the groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4488551, "edit_id": 0, "question": "What was the dosage of Astaxanthin given to the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4488551, "edit_id": 1, "question": "What kind of stress is induced by physical activity and how does it affect the body?", "category": "concept", "label": "concept"}, {"doc_id": 4488551, "edit_id": 2, "question": "What effect does Astaxanthin have on the body's inflammatory response to intense exercise?", "category": "concept", "label": "consequence"}, {"doc_id": 4493951, "edit_id": 0, "question": "What criteria were used to determine the high risk of nausea and vomiting in the women included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 1, "question": "When were the incidences of nausea, vomiting, use of other medicines to stop vomiting, pain, and side effects assessed after the surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4493951, "edit_id": 2, "question": "What specific adverse effects were the researchers looking for after the surgery?", "category": "omission", "label": "concept"}, {"doc_id": 4493951, "edit_id": 3, "question": "How was the sleepiness of the patients assessed after the surgery?", "category": "concept", "label": "procedural"}, {"doc_id": 4493951, "edit_id": 4, "question": "Was the difference in the total incidence of nausea and vomiting over 24 hours between the groups statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 4517637, "edit_id": 0, "question": "What statistical methods were used in the study to analyze the data?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 1, "question": "How were the valine kinetics and fractional albumin synthesis rate measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4517637, "edit_id": 2, "question": "How much protein was given in the high protein and normal protein diets?", "category": "concept", "label": "extent"}, {"doc_id": 4517637, "edit_id": 3, "question": "What were the specific values of valine synthesis rate and net valine balance in the high protein and normal protein groups?", "category": "concept", "label": "extent"}, {"doc_id": 4555141, "edit_id": 0, "question": "What type of study was this research a follow-up to?", "category": "omission", "label": "concept"}, {"doc_id": 4555141, "edit_id": 1, "question": "What specific tests were used to assess the children's cognitive and social-emotional skills?", "category": "omission", "label": "procedural"}, {"doc_id": 4555141, "edit_id": 2, "question": "How can micronutrient deficiencies affect early development?", "category": "concept", "label": "cause"}, {"doc_id": 4555141, "edit_id": 3, "question": "What was the main objective of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4562579, "edit_id": 0, "question": "What model did the researchers use to compare the effects of step-reduction and resistance training?", "category": "omission", "label": "comparison"}, {"doc_id": 4562579, "edit_id": 1, "question": "By what percentage were the subjects' daily steps reduced during the step-reduction period?", "category": "omission", "label": "extent"}, {"doc_id": 4562579, "edit_id": 2, "question": "How did the step-reduction and step-reduction plus resistance training conditions affect the subjects' leg fat-free mass?", "category": "omission", "label": "comparison"}, {"doc_id": 4562579, "edit_id": 3, "question": "What were the specific values of myofibrillar FSR in the step-reduction and step-reduction plus resistance training conditions?", "category": "concept", "label": "extent"}, {"doc_id": 4574984, "edit_id": 0, "question": "How were the patients assigned to the two groups in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 1, "question": "What tool was used to measure the health and life quality of the patients after a year?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 2, "question": "Besides measuring the hospital stay and life quality, what other objectives did the study have?", "category": "omission", "label": "concept"}, {"doc_id": 4574984, "edit_id": 3, "question": "How were the factors that determined the length of hospital stay identified?", "category": "omission", "label": "procedural"}, {"doc_id": 4574984, "edit_id": 4, "question": "What exactly did the intervention group receive compared to the control group?", "category": "concept", "label": "comparison"}, {"doc_id": 4574984, "edit_id": 5, "question": "What were the main outcomes that the study was interested in?", "category": "concept", "label": "concept"}, {"doc_id": 4574984, "edit_id": 6, "question": "What was the frequency of complications in the study and did it differ between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4577567, "edit_id": 0, "question": "How long was the training period and what was the incline of the uphill training?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 1, "question": "What were the names of the two groups and how many participants were in each group?", "category": "omission", "label": "extent"}, {"doc_id": 4577567, "edit_id": 2, "question": "What does stride length at iso-efficiency speed mean?", "category": "concept", "label": "concept"}, {"doc_id": 4577567, "edit_id": 3, "question": "What were the specific percentages of increase or decrease in stride length, contact time, stride frequency, and internal work in the group with structured step frequency?", "category": "concept", "label": "extent"}, {"doc_id": 4577567, "edit_id": 4, "question": "What were the specific percentages of increase or decrease in stride length, contact time, stride frequency, and internal work in the group without specific step frequency?", "category": "concept", "label": "extent"}, {"doc_id": 4599047, "edit_id": 0, "question": "What specific condition did the patients in the study suffer from?", "category": "omission", "label": "concept"}, {"doc_id": 4599047, "edit_id": 1, "question": "What tool was used to measure the success of the treatment?", "category": "omission", "label": "procedural"}, {"doc_id": 4599047, "edit_id": 2, "question": "What type of trial was conducted for the Superion\u00ae device?", "category": "concept", "label": "concept"}, {"doc_id": 4599047, "edit_id": 3, "question": "What does \"no clinically significant confounding treatments\" mean in the context of this study?", "category": "concept", "label": "concept"}, {"doc_id": 4609664, "edit_id": 0, "question": "What type of dental tools were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 1, "question": "How were the teeth divided into groups for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 2, "question": "How were the teeth prepared for examination after the treatments?", "category": "omission", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 3, "question": "What statistical methods were used to analyze the data from the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4609664, "edit_id": 4, "question": "What was the result of the study in terms of the damage caused by the different tools?", "category": "concept", "label": "consequence"}, {"doc_id": 4624894, "edit_id": 0, "question": "Why is the optimal treatment for this specific type of hepatitis C unclear?", "category": "omission", "label": "cause"}, {"doc_id": 4624894, "edit_id": 1, "question": "Why was the rapid virological response (RVR) considered important in this study?", "category": "omission", "label": "cause"}, {"doc_id": 4624894, "edit_id": 2, "question": "What specific drugs and dosages were used in the treatment for the first four weeks?", "category": "omission", "label": "procedural"}, {"doc_id": 4624894, "edit_id": 3, "question": "What does it mean when it is said that the patients were showing signs of improvement after four weeks?", "category": "concept", "label": "concept"}, {"doc_id": 4624894, "edit_id": 4, "question": "What were the specific success rates of the two groups in both the intention-to-treat analysis and the per-protocol analysis?", "category": "concept", "label": "extent"}, {"doc_id": 4687242, "edit_id": 0, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 4687242, "edit_id": 1, "question": "What statistical tests were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 2, "question": "What were the specific results of the study?", "category": "omission", "label": "consequence"}, {"doc_id": 4687242, "edit_id": 3, "question": "How was the World Health Organization's questionnaire administered?", "category": "concept", "label": "procedural"}, {"doc_id": 4687242, "edit_id": 4, "question": "How significant were the improvements in quality of life scores for the group taking Ashwagandha compared to the placebo group?", "category": "concept", "label": "extent"}, {"doc_id": 4704894, "edit_id": 0, "question": "What was the gender distribution of the participants in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4704894, "edit_id": 1, "question": "How significant was the engagement generated by Decisional Balance posts?", "category": "omission", "label": "extent"}, {"doc_id": 4704894, "edit_id": 2, "question": "Did any participant baseline characteristics significantly predict engagement?", "category": "omission", "label": "verification"}, {"doc_id": 4704894, "edit_id": 3, "question": "What is the name of the model used in the study to help people change their behavior?", "category": "concept", "label": "concept"}, {"doc_id": 4704894, "edit_id": 4, "question": "What specific components of the TTM were used in the study?", "category": "concept", "label": "concept"}, {"doc_id": 4704894, "edit_id": 5, "question": "What statistical method was used to analyze the data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4711101, "edit_id": 0, "question": "Where were the three international hospitals located that participated in the trial?", "category": "omission", "label": "concept"}, {"doc_id": 4711101, "edit_id": 1, "question": "What were the specific pain scores of the two groups two weeks after surgery?", "category": "omission", "label": "extent"}, {"doc_id": 4711101, "edit_id": 2, "question": "What was the difference in mean mechanical leg alignment between the two groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4711101, "edit_id": 3, "question": "What was the condition of the patients and what type of standard surgery did they receive?", "category": "concept", "label": "concept"}, {"doc_id": 4711101, "edit_id": 4, "question": "What were the primary and secondary outcomes of the study and what specific measurements were recorded?", "category": "concept", "label": "consequence"}, {"doc_id": 4717319, "edit_id": 0, "question": "How was the severity of schizophrenia symptoms measured and what was the change in this measurement for patients who showed improvement?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 1, "question": "What statistical measure was used to calculate the reduction in risk of relapse and what was its significance?", "category": "omission", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 2, "question": "How were the patients divided into the lurasidone and placebo groups?", "category": "concept", "label": "procedural"}, {"doc_id": 4717319, "edit_id": 3, "question": "How was the time to relapse analyzed in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4717613, "edit_id": 0, "question": "What type of lung cancer did the patients have and what type of surgery did they undergo?", "category": "omission", "label": "concept"}, {"doc_id": 4717613, "edit_id": 1, "question": "What were the specific nutrients included in the special diet?", "category": "omission", "label": "concept"}, {"doc_id": 4717613, "edit_id": 2, "question": "What were the exclusion criteria for the study?", "category": "omission", "label": "concept"}, {"doc_id": 4717613, "edit_id": 3, "question": "What specific protein levels were measured in the patients' blood?", "category": "concept", "label": "concept"}, {"doc_id": 4717613, "edit_id": 4, "question": "What were the average times for chest tube drainage in both the control and special diet groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4768925, "edit_id": 0, "question": "Has there been any previous research on how the drug affects inflammatory cytokines through the hypothalamus-pituitary-adrenal axis?", "category": "omission", "label": "verification"}, {"doc_id": 4768925, "edit_id": 1, "question": "What specific type of stroke did the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 4768925, "edit_id": 2, "question": "What method was used to measure the hormone levels and stroke scores in the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 3, "question": "What software was used to analyze the data from the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4768925, "edit_id": 4, "question": "How does the butylphthalide treatment affect the HPA axis and the prognosis of patients with acute basal ganglia infarction?", "category": "concept", "label": "consequence"}, {"doc_id": 4769147, "edit_id": 0, "question": "What were the specific names of the two groups in the study and how was the formula administered in the intervention group?", "category": "omission", "label": "procedural"}, {"doc_id": 4769147, "edit_id": 1, "question": "What were the specific percentages of weight loss in the CLF and SA groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4769147, "edit_id": 2, "question": "What other data, besides breastfeeding rates, were compared between the two groups and were any adjustments made in the statistical analysis?", "category": "concept", "label": "comparison"}, {"doc_id": 4769147, "edit_id": 3, "question": "What were the specific p-values associated with the comparison of breastfeeding rates at hospital discharge, at three months, and at six months?", "category": "concept", "label": "comparison"}, {"doc_id": 4784207, "edit_id": 0, "question": "What type of hospital was the study conducted in?", "category": "omission", "label": "concept"}, {"doc_id": 4784207, "edit_id": 1, "question": "What type of questionnaire was used to interview the patients and how were the responses measured?", "category": "omission", "label": "procedural"}, {"doc_id": 4784207, "edit_id": 2, "question": "What were the specific scores of the adequacy of consent index for both groups?", "category": "omission", "label": "comparison"}, {"doc_id": 4784207, "edit_id": 3, "question": "How did the separate written consent for anesthesia specifically improve the informed consent process?", "category": "concept", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 0, "question": "During which procedure is the renal graft stent used?", "category": "omission", "label": "procedural"}, {"doc_id": 4796524, "edit_id": 1, "question": "What severe consequence can stent complications lead to?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 2, "question": "What are the financial implications of stent complications?", "category": "omission", "label": "consequence"}, {"doc_id": 4796524, "edit_id": 3, "question": "What type of catheter was the stent attached to in the study group?", "category": "concept", "label": "procedural"}, {"doc_id": 4796524, "edit_id": 4, "question": "What specific urinary symptoms were compared between the two groups?", "category": "concept", "label": "comparison"}, {"doc_id": 4808872, "edit_id": 0, "question": "What specific exercise did the athletes perform to test their muscle strength?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 1, "question": "How was the optimal timing of PAP determined in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 2, "question": "What substance was used as a placebo in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 4808872, "edit_id": 3, "question": "How did the optimal individual PAP time change in the creatine group compared to the placebo group?", "category": "concept", "label": "comparison"}, {"doc_id": 4877819, "edit_id": 0, "question": "What specific measures were used to assess disability, inflammation, and radiological findings in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 1, "question": "What was the specific dosage and frequency of the A. paniculata extract given to the patients in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 2, "question": "How was fatigue measured in the study and what was the exact percentage of reduction in fatigue in patients treated with A. paniculata?", "category": "concept", "label": "procedural"}, {"doc_id": 4877819, "edit_id": 3, "question": "What type of medication was used to treat the skin rash developed by one patient taking A. paniculata?", "category": "concept", "label": "concept"}, {"doc_id": 4893758, "edit_id": 0, "question": "Why is the study of pain relief methods important for emergency physicians?", "category": "omission", "label": "cause"}, {"doc_id": 4893758, "edit_id": 1, "question": "What were the specific results of the study in terms of procedure duration, pain reduction, failure rate, and patient satisfaction?", "category": "omission", "label": "consequence"}, {"doc_id": 4893758, "edit_id": 2, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 4893758, "edit_id": 3, "question": "How many adverse events were reported in each group and what was the percentage of these events?", "category": "concept", "label": "extent"}, {"doc_id": 4914313, "edit_id": 0, "question": "What phase was the clinical trial in?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 1, "question": "What specific drugs were used in the treatment groups?", "category": "omission", "label": "concept"}, {"doc_id": 4914313, "edit_id": 2, "question": "What were the specific median progression free survival and overall survival rates for the treatment groups?", "category": "omission", "label": "consequence"}, {"doc_id": 4914313, "edit_id": 3, "question": "What were the specific progression free survival and overall survival rates for patients with high and low levels of miR-21?", "category": "concept", "label": "consequence"}, {"doc_id": 4914313, "edit_id": 4, "question": "What does the level of miR-21 in the blood indicate about the disease in the body?", "category": "concept", "label": "concept"}, {"doc_id": 4937273, "edit_id": 0, "question": "Is the every-4-weeks dosing of alirocumab approved?", "category": "omission", "label": "verification"}, {"doc_id": 4937273, "edit_id": 1, "question": "What were the criteria for the subjects included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4937273, "edit_id": 2, "question": "What were the specific percentages of LDL-C reductions in each group?", "category": "concept", "label": "consequence"}, {"doc_id": 4937273, "edit_id": 3, "question": "How did the free PCSK9 concentrations and alirocumab levels change over time?", "category": "concept", "label": "comparison"}, {"doc_id": 4941128, "edit_id": 0, "question": "What were the results of the previous trial of unilateral aDBS?", "category": "omission", "label": "consequence"}, {"doc_id": 4941128, "edit_id": 1, "question": "Where was the DBS applied in the patients?", "category": "omission", "label": "concept"}, {"doc_id": 4941128, "edit_id": 2, "question": "What was the mean stimulation voltage used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 4941128, "edit_id": 3, "question": "What scoring system was used to measure the patients' movement and coordination?", "category": "concept", "label": "procedural"}, {"doc_id": 4941128, "edit_id": 4, "question": "How significant was the improvement in the patients' coordination and movement scores with aDBS treatment?", "category": "concept", "label": "extent"}, {"doc_id": 4967511, "edit_id": 0, "question": "When were the primary school classes recruited for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 1, "question": "What were the eligibility criteria for the primary school classes to participate in the study?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 2, "question": "How long did the study last and how much training did the teachers receive?", "category": "omission", "label": "procedural"}, {"doc_id": 4967511, "edit_id": 3, "question": "What is the registration number and date of the study in the German register of clinical studies?", "category": "omission", "label": "concept"}, {"doc_id": 4967511, "edit_id": 4, "question": "What specific physical skills improved in the group that received the program?", "category": "concept", "label": "consequence"}, {"doc_id": 4967511, "edit_id": 5, "question": "Were the assessors aware of which group each class was assigned to during the study?", "category": "concept", "label": "verification"}, {"doc_id": 4972969, "edit_id": 0, "question": "Who designed and implemented the training approaches in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4972969, "edit_id": 1, "question": "How were the health facilities divided for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 4972969, "edit_id": 2, "question": "How many outpatient visits occurred during the study period?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 3, "question": "How many health workers provided treatment during the study?", "category": "omission", "label": "extent"}, {"doc_id": 4972969, "edit_id": 4, "question": "Where can one find supplementary material related to this study?", "category": "omission", "label": "procedural"}, {"doc_id": 4972969, "edit_id": 5, "question": "What were the specific statistical values found for the effect of on-site guidance on the number of patients a health worker saw each day?", "category": "concept", "label": "consequence"}, {"doc_id": 4984916, "edit_id": 0, "question": "What phase was the trial in?", "category": "omission", "label": "procedural"}, {"doc_id": 4984916, "edit_id": 1, "question": "What was the ratio of patients randomized to receive a Hickman or a TIVAS?", "category": "omission", "label": "extent"}, {"doc_id": 4984916, "edit_id": 2, "question": "How many questions did the TIVAS score higher on in the device-specific questionnaire?", "category": "omission", "label": "comparison"}, {"doc_id": 4984916, "edit_id": 3, "question": "What was the mean cost per patient and quality-adjusted life years for the Hickman arm?", "category": "concept", "label": "extent"}, {"doc_id": 4984916, "edit_id": 4, "question": "What was the percentage of devices removed prematurely in the Hickman and TIVAS arms?", "category": "concept", "label": "extent"}, {"doc_id": 4994121, "edit_id": 0, "question": "What specific procedure did the patients in the study require in addition to the heart bypass surgery?", "category": "omission", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 1, "question": "What was the cause of death for the five patients who died after surgery?", "category": "omission", "label": "cause"}, {"doc_id": 4994121, "edit_id": 2, "question": "What were the specific dosages of the drugs used, and when were they administered in relation to the surgery?", "category": "concept", "label": "procedural"}, {"doc_id": 4994121, "edit_id": 3, "question": "What was considered a significant drop in blood pressure, and what solution was used to correct it?", "category": "concept", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 0, "question": "What specific type of exergaming intervention was examined in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5002324, "edit_id": 1, "question": "What were the stages of Parkinson's disease of the participants in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5002324, "edit_id": 2, "question": "How was postural stability assessed in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 3, "question": "What was the design of the study?", "category": "concept", "label": "concept"}, {"doc_id": 5002324, "edit_id": 4, "question": "Which tests were used to assess balance in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5002324, "edit_id": 5, "question": "In what aspect did the group that did the Kinect exergame improve more than the group that did traditional training?", "category": "concept", "label": "comparison"}, {"doc_id": 5018291, "edit_id": 0, "question": "What were the specific treatments given to each group in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 1, "question": "How were the pain levels measured and how significant were the results?", "category": "concept", "label": "procedural"}, {"doc_id": 5018291, "edit_id": 2, "question": "What were the specific secondary objectives of the study?", "category": "concept", "label": "concept"}, {"doc_id": 5019463, "edit_id": 0, "question": "Where and how was the study conducted?", "category": "omission", "label": "procedural"}, {"doc_id": 5019463, "edit_id": 1, "question": "How were the adherence rates compared among the three groups?", "category": "omission", "label": "comparison"}, {"doc_id": 5019463, "edit_id": 2, "question": "What was the average number of follow-up visits for each group during the study period?", "category": "concept", "label": "extent"}, {"doc_id": 5019463, "edit_id": 3, "question": "What were the specific adherence rates for each group?", "category": "concept", "label": "extent"}, {"doc_id": 5019971, "edit_id": 0, "question": "What type of study was conducted to test the effects of Maraviroc?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 1, "question": "What was the condition of the HIV in the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 2, "question": "What health markers were measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5019971, "edit_id": 3, "question": "How much did Maraviroc improve blood flow in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5019971, "edit_id": 4, "question": "What specific relationships were found between improvements in blood flow and inflammation, as well as immune activation?", "category": "concept", "label": "concept"}, {"doc_id": 5043523, "edit_id": 0, "question": "What specific alleles of the MTHFR gene were considered risk and non-risk in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5043523, "edit_id": 1, "question": "What statistical method was used to analyze the changes in folate intake?", "category": "omission", "label": "procedural"}, {"doc_id": 5043523, "edit_id": 2, "question": "What were the specific baseline folate intake values for the risk, non-risk, and control groups?", "category": "concept", "label": "extent"}, {"doc_id": 5043523, "edit_id": 3, "question": "What specific genotype did the study find did not improve folate intake in participants with the risk variant compared with those with the non-risk variant?", "category": "concept", "label": "concept"}, {"doc_id": 5054596, "edit_id": 0, "question": "What kind of objects did the participants have to manipulate during the study?", "category": "omission", "label": "concept"}, {"doc_id": 5054596, "edit_id": 1, "question": "What specific procedure was used to measure the performance of the participants?", "category": "omission", "label": "procedural"}, {"doc_id": 5054596, "edit_id": 2, "question": "Where can one find the online version of this article?", "category": "omission", "label": "concept"}, {"doc_id": 5054596, "edit_id": 3, "question": "What was the physical condition of the participants in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5054596, "edit_id": 4, "question": "What aspect of the participants' performance was influenced by the type of training?", "category": "concept", "label": "consequence"}, {"doc_id": 5054596, "edit_id": 5, "question": "What specific aspect of the training helped users get better at real-world tasks?", "category": "concept", "label": "cause"}, {"doc_id": 5117579, "edit_id": 0, "question": "What type of drug is Dexmedetomidine?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 1, "question": "What drug was used for spinal anesthesia in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5117579, "edit_id": 2, "question": "How were the patients' anxiety and comfort levels measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 3, "question": "How was the health status of the patients in the study classified?", "category": "concept", "label": "procedural"}, {"doc_id": 5117579, "edit_id": 4, "question": "How was dexmedetomidine administered to the patients in Group A?", "category": "concept", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 0, "question": "What type of clinical trial was conducted in this study?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 1, "question": "Where and when was this study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5122106, "edit_id": 2, "question": "What statistical methods were used in this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5122106, "edit_id": 3, "question": "Who were the individuals that dropped out of the study?", "category": "concept", "label": "concept"}, {"doc_id": 5122106, "edit_id": 4, "question": "How much weight did the participants in the case group and the control group lose?", "category": "concept", "label": "extent"}, {"doc_id": 5122238, "edit_id": 0, "question": "Why is the study looking into the effects of hydrocortisone on shivering after surgery?", "category": "omission", "label": "cause"}, {"doc_id": 5122238, "edit_id": 1, "question": "How did the researchers determine that the differences in shivering incidence among the three groups were not due to chance?", "category": "concept", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 0, "question": "At what rate was the propofol administered to the patients?", "category": "omission", "label": "extent"}, {"doc_id": 5125190, "edit_id": 1, "question": "How was the pain evaluated in the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 2, "question": "What specific statistical tests were used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5125190, "edit_id": 3, "question": "How was the methylprednisolone administered to the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 5125721, "edit_id": 0, "question": "Besides urinary albumin to creatinine ratio and urea nitrogen, were there any other markers tested in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5125721, "edit_id": 1, "question": "What was the control group's diet like in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5125721, "edit_id": 2, "question": "What was the specific hypothesis of the study regarding the effect of Tartary buckwheat?", "category": "concept", "label": "concept"}, {"doc_id": 5125721, "edit_id": 3, "question": "How much did the urinary albumin to creatinine ratio and urea nitrogen levels decrease in the group that ate Tartary buckwheat?", "category": "concept", "label": "extent"}, {"doc_id": 5125721, "edit_id": 4, "question": "What stages of diabetic kidney disease were considered in the subgroup analysis?", "category": "concept", "label": "concept"}, {"doc_id": 5125808, "edit_id": 0, "question": "What are the components of CKD-828 and what are their functions?", "category": "omission", "label": "concept"}, {"doc_id": 5125808, "edit_id": 1, "question": "What were the criteria for patients to be eligible for this study?", "category": "omission", "label": "concept"}, {"doc_id": 5125808, "edit_id": 2, "question": "What were the rates of adverse events in the different treatment groups?", "category": "omission", "label": "extent"}, {"doc_id": 5125808, "edit_id": 3, "question": "What were the exact doses of CKD-828 given to the patients?", "category": "concept", "label": "extent"}, {"doc_id": 5125808, "edit_id": 4, "question": "What was the primary measure of how well the treatments worked?", "category": "concept", "label": "concept"}, {"doc_id": 5129820, "edit_id": 0, "question": "What is the main benefit of using olaparib in patients with platinum-sensitive relapsed serous ovarian cancer?", "category": "omission", "label": "consequence"}, {"doc_id": 5129820, "edit_id": 1, "question": "In which group of patients is the greatest benefit of olaparib seen?", "category": "omission", "label": "comparison"}, {"doc_id": 5129820, "edit_id": 2, "question": "What is an important aspect to consider during maintenance therapy with olaparib?", "category": "omission", "label": "concept"}, {"doc_id": 5129820, "edit_id": 3, "question": "What specific surveys were used to evaluate patient-reported health-related quality of life and disease-related symptoms, and which was the primary measure?", "category": "concept", "label": "procedural"}, {"doc_id": 5129820, "edit_id": 4, "question": "What was the response of the patients in the study to their most recent platinum-based therapy?", "category": "concept", "label": "consequence"}, {"doc_id": 5223669, "edit_id": 0, "question": "What is the nature of the cLDA technique used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5223669, "edit_id": 1, "question": "What type of models were used to fit the data in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5223669, "edit_id": 2, "question": "How did the 95% confidence interval (CI) coverage compare between ANCOVA and cLDA?", "category": "omission", "label": "comparison"}, {"doc_id": 5223669, "edit_id": 3, "question": "What does cLDA yield under reasonable missing data assumptions?", "category": "concept", "label": "consequence"}, {"doc_id": 5223669, "edit_id": 4, "question": "How does cLDA compare to ANCOVA and LDA in terms of preference?", "category": "concept", "label": "comparison"}, {"doc_id": 5244020, "edit_id": 0, "question": "What type of study was conducted to test the effects of lavender oil and linalyl acetate?", "category": "omission", "label": "concept"}, {"doc_id": 5244020, "edit_id": 1, "question": "What was the concentration of lavender and linalyl acetate that the patients inhaled?", "category": "omission", "label": "extent"}, {"doc_id": 5244020, "edit_id": 2, "question": "What specific measurements were taken before and after the inhalation?", "category": "concept", "label": "procedural"}, {"doc_id": 5244020, "edit_id": 3, "question": "How did the effects of inhaling linalyl acetate compare to the effects of inhaling lavender or the control substance?", "category": "concept", "label": "comparison"}, {"doc_id": 5301061, "edit_id": 0, "question": "What aspects of spiritual wellbeing were measured in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5301061, "edit_id": 1, "question": "What type of study was conducted to examine the effects of the religious program?", "category": "concept", "label": "concept"}, {"doc_id": 5301061, "edit_id": 2, "question": "What specific tool was used to measure the spiritual wellbeing of the participants?", "category": "concept", "label": "procedural"}, {"doc_id": 5301061, "edit_id": 3, "question": "What specific statistical tests were used to analyze the data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 0, "question": "Under what specific conditions were additional fluid packs given to the patients in the GDFR group?", "category": "omission", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 1, "question": "What were the specific numbers and percentages of complications in the GDFR and control groups?", "category": "omission", "label": "extent"}, {"doc_id": 5313491, "edit_id": 2, "question": "How were the patients assigned to the control and GDFR groups?", "category": "concept", "label": "procedural"}, {"doc_id": 5313491, "edit_id": 3, "question": "What type of fluid was used in the GDFR group?", "category": "concept", "label": "concept"}, {"doc_id": 5313491, "edit_id": 4, "question": "What were the specific lengths of stay in the ICU for the GDFR and control groups?", "category": "concept", "label": "extent"}, {"doc_id": 5350209, "edit_id": 0, "question": "What kind of health-warning messages were used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5350209, "edit_id": 1, "question": "What is the effect of the speed of alcohol consumption?", "category": "omission", "label": "consequence"}, {"doc_id": 5350209, "edit_id": 2, "question": "What were the conditions under which the participants consumed the alcoholic beverage?", "category": "concept", "label": "procedural"}, {"doc_id": 5350209, "edit_id": 3, "question": "How was the rate of consumption measured in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 0, "question": "What type of analysis was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5379203, "edit_id": 1, "question": "What diagnostic methods were used to detect OSAS in the patients of each group?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 2, "question": "What specific measure was used to assess sleep quality and life quality, and what were the statistical results?", "category": "omission", "label": "procedural"}, {"doc_id": 5379203, "edit_id": 3, "question": "What were the mean costs for patients in each group?", "category": "concept", "label": "extent"}, {"doc_id": 5379203, "edit_id": 4, "question": "What were the exact waiting times for each stage of the process in each group?", "category": "concept", "label": "extent"}, {"doc_id": 5416724, "edit_id": 0, "question": "What specific technique was used for neck immobilisation in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 1, "question": "What specific scales and parameters were used to measure the ease of intubation and the view of the throat area?", "category": "omission", "label": "procedural"}, {"doc_id": 5416724, "edit_id": 2, "question": "How much easier was the intubation process with the Airtraq device compared to the other two devices, according to the study's results?", "category": "concept", "label": "comparison"}, {"doc_id": 5416724, "edit_id": 3, "question": "How did the use of the Airtraq device affect the patients' heart rates and blood pressure levels compared to the other two devices?", "category": "concept", "label": "comparison"}, {"doc_id": 5433398, "edit_id": 0, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5433398, "edit_id": 1, "question": "What specific scale was used to measure the patients' quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 5433398, "edit_id": 2, "question": "What were the specific changes in the quality of life scores of the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 5433398, "edit_id": 3, "question": "What variables were adjusted for in the analysis?", "category": "concept", "label": "concept"}, {"doc_id": 5440036, "edit_id": 0, "question": "What specific type of eye surgery were the patients undergoing?", "category": "omission", "label": "concept"}, {"doc_id": 5440036, "edit_id": 1, "question": "What were the exact dosages of the drugs given to each group?", "category": "omission", "label": "procedural"}, {"doc_id": 5440036, "edit_id": 2, "question": "What does it mean for a patient to be in the American Society of Anesthesiologists Classes I and II?", "category": "concept", "label": "concept"}, {"doc_id": 5440036, "edit_id": 3, "question": "What does the complete response (CR) rate refer to in this study?", "category": "concept", "label": "concept"}, {"doc_id": 5440738, "edit_id": 0, "question": "What tool was used to measure the severity of depression symptoms in the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 1, "question": "How were the mood data and qualitative responses from the text messaging service used in the therapy sessions?", "category": "omission", "label": "procedural"}, {"doc_id": 5440738, "edit_id": 2, "question": "How significant was the difference in therapy duration between the group that received text messages and the group that didn't?", "category": "concept", "label": "extent"}, {"doc_id": 5440738, "edit_id": 3, "question": "How significant was the decrease in depressive symptom severity in both groups?", "category": "concept", "label": "extent"}, {"doc_id": 5442667, "edit_id": 0, "question": "What type of intervention was used in the study to address inappropriate medication use?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 1, "question": "What specific measures were used to evaluate the outcomes of the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5442667, "edit_id": 2, "question": "When and where was the study registered?", "category": "omission", "label": "concept"}, {"doc_id": 5442667, "edit_id": 3, "question": "What were the exact demographic details of the participants in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5442667, "edit_id": 4, "question": "What were the exact changes in the MAI and ADS scores for the intervention and control groups?", "category": "concept", "label": "extent"}, {"doc_id": 5448649, "edit_id": 0, "question": "What was the previous treatment status of the patients included in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5448649, "edit_id": 1, "question": "How were the peptides for the personalized peptide vaccination (PPV) selected and administered?", "category": "omission", "label": "procedural"}, {"doc_id": 5448649, "edit_id": 2, "question": "What were the specific survival rates for the patients who received the combination of CPA and PPV compared to those who received only PPV?", "category": "concept", "label": "comparison"}, {"doc_id": 5448649, "edit_id": 3, "question": "What was the effect of the treatments on the levels of IL-6 protein in the patients' plasma?", "category": "concept", "label": "consequence"}, {"doc_id": 5491994, "edit_id": 0, "question": "What specific 3D printing method was used to create the model of the human nasal sinus?", "category": "omission", "label": "procedural"}, {"doc_id": 5491994, "edit_id": 1, "question": "What type of data was used to create the 3D model of the human nasal sinus?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 2, "question": "What was the design of the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5491994, "edit_id": 3, "question": "How was the model's material, anatomical accuracy, and overall appearance optimized?", "category": "concept", "label": "procedural"}, {"doc_id": 5491994, "edit_id": 4, "question": "How significant were the improvements in patient ratings and self-rated understanding?", "category": "concept", "label": "extent"}, {"doc_id": 5498715, "edit_id": 0, "question": "What specific questionnaires were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 1, "question": "How was the validity and reliability of the questionnaires ensured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5498715, "edit_id": 2, "question": "What is the specific registration ID of the trial?", "category": "omission", "label": "concept"}, {"doc_id": 5498715, "edit_id": 3, "question": "What were the specific statistical results of the study?", "category": "concept", "label": "consequence"}, {"doc_id": 5498715, "edit_id": 4, "question": "What were the specific statistical results of the study regarding the psychological aspects?", "category": "concept", "label": "consequence"}, {"doc_id": 5506592, "edit_id": 0, "question": "What type of trial was the Camino Verde project?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 1, "question": "How were the communities for the Camino Verde project selected and where were they located?", "category": "omission", "label": "procedural"}, {"doc_id": 5506592, "edit_id": 2, "question": "What was the relationship between the expenditures on anti-mosquito products and social vulnerability?", "category": "omission", "label": "consequence"}, {"doc_id": 5506592, "edit_id": 3, "question": "What type of intervention was used in the Camino Verde project?", "category": "omission", "label": "concept"}, {"doc_id": 5506592, "edit_id": 4, "question": "What percentage of households in the intervention and control groups spent more than the average on anti-mosquito products?", "category": "concept", "label": "extent"}, {"doc_id": 5506697, "edit_id": 0, "question": "What were the specific criteria used to select patients for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 1, "question": "What statistical methods were used in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 2, "question": "What specific improvements in depression symptoms were observed in the group that received the drug combination?", "category": "omission", "label": "consequence"}, {"doc_id": 5506697, "edit_id": 3, "question": "What were the specific doses of the drugs used and how many patients were in each group?", "category": "concept", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 4, "question": "What specific questionnaire was used to measure quality of life?", "category": "concept", "label": "procedural"}, {"doc_id": 5506697, "edit_id": 5, "question": "What is the specific registration information for the clinical trial?", "category": "concept", "label": "concept"}, {"doc_id": 5513842, "edit_id": 0, "question": "How many patients were initially recruited for the study and how many of them completed it?", "category": "omission", "label": "extent"}, {"doc_id": 5513842, "edit_id": 1, "question": "What were the specific pain scores of the patients at rest and during movement 24 hours after surgery?", "category": "omission", "label": "consequence"}, {"doc_id": 5513842, "edit_id": 2, "question": "How much opioid medication did the patients in both groups consume 24 hours after surgery?", "category": "concept", "label": "extent"}, {"doc_id": 5513842, "edit_id": 3, "question": "How long did the patients in the PVB group wait before they required their first analgesic after surgery?", "category": "concept", "label": "extent"}, {"doc_id": 5514258, "edit_id": 0, "question": "What was the state of evidence regarding the use of postoperative radiation for salivary gland malignancies before this study?", "category": "omission", "label": "concept"}, {"doc_id": 5514258, "edit_id": 1, "question": "What source of data did the researchers use for this study?", "category": "omission", "label": "procedural"}, {"doc_id": 5514258, "edit_id": 2, "question": "What were the specific criteria used to categorize patients into high and intermediate risk groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5514258, "edit_id": 3, "question": "What were the specific statistical results for the survival of high-risk patients who received adjuvant radiation therapy?", "category": "concept", "label": "consequence"}, {"doc_id": 5514258, "edit_id": 4, "question": "What were the two treatment options compared in the study?", "category": "concept", "label": "comparison"}, {"doc_id": 5518918, "edit_id": 0, "question": "What was the probability that home-based training was more cost-effective than center-based training?", "category": "omission", "label": "extent"}, {"doc_id": 5518918, "edit_id": 1, "question": "What are some of the issues with cardiac rehabilitation?", "category": "concept", "label": "concept"}, {"doc_id": 5518918, "edit_id": 2, "question": "How long did the training last for the patients?", "category": "concept", "label": "extent"}, {"doc_id": 5518918, "edit_id": 3, "question": "Was the improvement in physical fitness statistically significant?", "category": "concept", "label": "verification"}, {"doc_id": 5529957, "edit_id": 0, "question": "What was the name of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5529957, "edit_id": 1, "question": "What was the condition of some of the patients after a certain surgery?", "category": "omission", "label": "consequence"}, {"doc_id": 5529957, "edit_id": 2, "question": "What was the dosage of riociguat given to the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 5529957, "edit_id": 3, "question": "What were the specific effects of riociguat on pulmonary vascular resistance in both groups of patients?", "category": "concept", "label": "consequence"}, {"doc_id": 5529957, "edit_id": 4, "question": "What were the specific effects of riociguat on mean pulmonary artery pressure in both groups of patients?", "category": "concept", "label": "consequence"}, {"doc_id": 5545112, "edit_id": 0, "question": "What statistical method was used to assess the differences in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5545112, "edit_id": 1, "question": "How much did the vitamin D levels increase in each group after 90 days?", "category": "omission", "label": "extent"}, {"doc_id": 5545112, "edit_id": 2, "question": "What type of study was conducted?", "category": "concept", "label": "concept"}, {"doc_id": 5545112, "edit_id": 3, "question": "How low were the vitamin D levels in patients that were included in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5545112, "edit_id": 4, "question": "What survey was used to measure participants' quality of life?", "category": "concept", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 0, "question": "What was the name and type of the trial conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5555437, "edit_id": 1, "question": "How many centres and countries were involved in the trial?", "category": "omission", "label": "extent"}, {"doc_id": 5555437, "edit_id": 2, "question": "What method was used to allocate patients to the different treatment groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 3, "question": "Is the study registered and what is its current status?", "category": "omission", "label": "verification"}, {"doc_id": 5555437, "edit_id": 4, "question": "Which specific organizations funded the study?", "category": "omission", "label": "example"}, {"doc_id": 5555437, "edit_id": 5, "question": "What were the specific details of the radiotherapy and chemotherapy treatments given to the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 5555437, "edit_id": 6, "question": "What were the confidence intervals for the median overall survival times in the twice-daily and once-daily groups?", "category": "concept", "label": "extent"}, {"doc_id": 5555437, "edit_id": 7, "question": "What were the confidence intervals for the 2-year overall survival rates in the twice-daily and once-daily groups?", "category": "concept", "label": "extent"}, {"doc_id": 5555437, "edit_id": 8, "question": "What were the specific numbers and percentages of patients who experienced neutropenia in the twice-daily and once-daily groups?", "category": "concept", "label": "extent"}, {"doc_id": 5571493, "edit_id": 0, "question": "What were the specific average blood sugar levels during the 4-hour infusion with and without quinine, both in the saline and glucose solutions?", "category": "omission", "label": "comparison"}, {"doc_id": 5571493, "edit_id": 1, "question": "What was the specific blood sugar level at the 60th minute and how much did it decrease from the initial level?", "category": "concept", "label": "extent"}, {"doc_id": 5571493, "edit_id": 2, "question": "Did quinine cause a significant change in blood sugar levels when glucose was used compared to when saline was used?", "category": "concept", "label": "cause"}, {"doc_id": 5588713, "edit_id": 0, "question": "What type of study was conducted to test the effects of carbon nanoparticles?", "category": "omission", "label": "concept"}, {"doc_id": 5588713, "edit_id": 1, "question": "What were the specific doses of carbon nanoparticles used in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 2, "question": "How significant was the increase in neutrophils in blood when the top-dose of 100 \u03bcg was used?", "category": "omission", "label": "extent"}, {"doc_id": 5588713, "edit_id": 3, "question": "How small are the nanoparticles referred to in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5588713, "edit_id": 4, "question": "What is the technical term for the \"washings from lung fluid\" collected in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5588713, "edit_id": 5, "question": "What specific type of white blood cells increased in number due to the carbon nanoparticles?", "category": "concept", "label": "concept"}, {"doc_id": 5626376, "edit_id": 0, "question": "What specific measure was used to determine if there was significant improvement in the patients' symptoms?", "category": "omission", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 1, "question": "What specific type of platelet-rich plasma (PRP) was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5626376, "edit_id": 2, "question": "Can you provide more details about the design of the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5626376, "edit_id": 3, "question": "What were the exact percentages of improvement for each group at 18 months, and how did the control group fare?", "category": "concept", "label": "comparison"}, {"doc_id": 5626376, "edit_id": 4, "question": "What were the exact percentages of patients achieving the Minimally Clinical Important Improvement in each group, and what happened to the patients in the control group?", "category": "concept", "label": "comparison"}, {"doc_id": 5682159, "edit_id": 0, "question": "Were there any restrictions during the treatment process in the study?", "category": "omission", "label": "verification"}, {"doc_id": 5682159, "edit_id": 1, "question": "How did the participants assess the aesthetic improvements in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5682159, "edit_id": 2, "question": "How severe was the volume loss in the cheeks of the participants in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5682159, "edit_id": 3, "question": "What were the specific percentages of participants who reported improvement at different time points for each filler?", "category": "concept", "label": "extent"}, {"doc_id": 5702778, "edit_id": 0, "question": "How many specimens were used for the microhardness tests and the scanning electron microscopy tests?", "category": "omission", "label": "extent"}, {"doc_id": 5702778, "edit_id": 1, "question": "What statistical tests were used to compare the microhardness changes in different groups?", "category": "omission", "label": "procedural"}, {"doc_id": 5702778, "edit_id": 2, "question": "How significant were the differences in enamel hardness between the groups?", "category": "concept", "label": "extent"}, {"doc_id": 5702778, "edit_id": 3, "question": "Which group had enamel hardness changes that were not significantly greater than those in the control group?", "category": "concept", "label": "disjunction"}, {"doc_id": 5730627, "edit_id": 0, "question": "What was the age range of the participants and how was their ADHD diagnosed?", "category": "omission", "label": "concept"}, {"doc_id": 5730627, "edit_id": 1, "question": "Are there any registry numbers associated with these clinical trials?", "category": "omission", "label": "verification"}, {"doc_id": 5730627, "edit_id": 2, "question": "What were the specific dosages of the drugs given in the flexible and forced-dose studies, and how many participants were in each group?", "category": "concept", "label": "procedural"}, {"doc_id": 5730627, "edit_id": 3, "question": "What was the frequency of side effects for LDX and OROS-MPH in the forced-dose and flexible-dose studies?", "category": "concept", "label": "extent"}, {"doc_id": 5771057, "edit_id": 0, "question": "What specific subtests from the Woodcock\u2013Johnson III were administered to the participants?", "category": "omission", "label": "procedural"}, {"doc_id": 5771057, "edit_id": 1, "question": "What were the specific dual-task experimental conditions that the participants were tested in?", "category": "omission", "label": "concept"}, {"doc_id": 5771057, "edit_id": 2, "question": "What statistical method was used to analyze the data?", "category": "concept", "label": "procedural"}, {"doc_id": 5771057, "edit_id": 3, "question": "What statistical method was used to determine the predictive power of the cognitive subtests?", "category": "concept", "label": "procedural"}, {"doc_id": 5805261, "edit_id": 0, "question": "What specific type of liver cancer did the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5805261, "edit_id": 1, "question": "What were some of the technical parameters that were evaluated in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5805261, "edit_id": 2, "question": "What happened to the patients who experienced a technical issue or major side effect?", "category": "concept", "label": "consequence"}, {"doc_id": 5805261, "edit_id": 3, "question": "What were the exact 1-year and 2-year local tumor progression free survival rates for each group?", "category": "concept", "label": "extent"}, {"doc_id": 5808396, "edit_id": 0, "question": "How were the women recruited for the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5808396, "edit_id": 1, "question": "Where specifically in the Democratic Republic of Congo was the study conducted?", "category": "omission", "label": "concept"}, {"doc_id": 5808396, "edit_id": 2, "question": "What type of statistical model was used in the study and what was it used to estimate?", "category": "concept", "label": "procedural"}, {"doc_id": 5808396, "edit_id": 3, "question": "How significant was the reduction in stigma among the women who received Cognitive Processing Therapy compared to those who received individual support?", "category": "concept", "label": "extent"}, {"doc_id": 5809707, "edit_id": 0, "question": "How was the consumption of propofol measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 1, "question": "What specific scale was used to measure the time to recovery in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5809707, "edit_id": 2, "question": "How much propofol was consumed by each group in the study?", "category": "concept", "label": "extent"}, {"doc_id": 5809707, "edit_id": 3, "question": "What were the specific doses of fentanyl and ketamine used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 0, "question": "What type of laser was used in the study and what were its specifications?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 1, "question": "How was the patients' tooth sensitivity measured in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 2, "question": "What was the concentration of potassium nitrate used in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5827507, "edit_id": 3, "question": "How were the results of the study statistically analyzed and what was the significance level of the results?", "category": "concept", "label": "procedural"}, {"doc_id": 5852865, "edit_id": 0, "question": "What was the dosage of the supplements given to the participants in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5852865, "edit_id": 1, "question": "What was the specific increase in macular pigment optical density in both groups?", "category": "omission", "label": "extent"}, {"doc_id": 5852865, "edit_id": 2, "question": "Was the difference in the increase of macular pigment optical density between the two groups statistically significant?", "category": "omission", "label": "verification"}, {"doc_id": 5852865, "edit_id": 3, "question": "What are the three components that make up the macula?", "category": "concept", "label": "concept"}, {"doc_id": 5852865, "edit_id": 4, "question": "Was the trend of smaller increases in macular pigment for those with higher baseline values statistically significant in the group taking the supplement with all three components?", "category": "concept", "label": "verification"}, {"doc_id": 5853038, "edit_id": 0, "question": "Is this study unique in any way in the United Arab Emirates?", "category": "omission", "label": "verification"}, {"doc_id": 5853038, "edit_id": 1, "question": "What statistical methods were used to analyze the data in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5853038, "edit_id": 2, "question": "What are the active ingredients in the toothpastes tested in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5853038, "edit_id": 3, "question": "How was the reduction in plaque measured and how significant was the difference between the two toothpastes?", "category": "concept", "label": "procedural"}, {"doc_id": 5861369, "edit_id": 0, "question": "What specific tests were conducted on the patients during the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5861369, "edit_id": 1, "question": "What specific questionnaires were used to assess the patients' mental health and quality of life?", "category": "omission", "label": "procedural"}, {"doc_id": 5861369, "edit_id": 2, "question": "What was the range of ages, BMIs, and waist measurements of the participants?", "category": "concept", "label": "extent"}, {"doc_id": 5861369, "edit_id": 3, "question": "What were the specific changes in waist size and cortisol levels in the escitalopram group, and how significant were these changes compared to the placebo group?", "category": "concept", "label": "comparison"}, {"doc_id": 5863413, "edit_id": 0, "question": "What is the standard treatment for oral lichen planus?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 1, "question": "What type of oral lichen planus did the patients in the study have?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 2, "question": "What specific steroid was used in the control group?", "category": "omission", "label": "concept"}, {"doc_id": 5863413, "edit_id": 3, "question": "How were the patients' pain and erythema evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5863413, "edit_id": 4, "question": "What are some characteristics of lichen planus?", "category": "concept", "label": "concept"}, {"doc_id": 5863413, "edit_id": 5, "question": "How effective was propolis compared to the specific steroid used in the study?", "category": "concept", "label": "comparison"}, {"doc_id": 5866486, "edit_id": 0, "question": "What type of head trauma patients did the study focus on?", "category": "omission", "label": "concept"}, {"doc_id": 5866486, "edit_id": 1, "question": "What specific medication was used in the study?", "category": "omission", "label": "concept"}, {"doc_id": 5866486, "edit_id": 2, "question": "How significant were the results of the study?", "category": "omission", "label": "extent"}, {"doc_id": 5866486, "edit_id": 3, "question": "Who checked and approved the individualized vestibular rehabilitation program?", "category": "concept", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 0, "question": "What was the average age of the patients in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5891985, "edit_id": 1, "question": "How were the drugs liraglutide and metformin administered to the patients?", "category": "omission", "label": "procedural"}, {"doc_id": 5891985, "edit_id": 2, "question": "Was there any correlation observed between the reduction of harmful fats and the molecule linked to blood vessel damage after liraglutide treatment?", "category": "omission", "label": "verification"}, {"doc_id": 5891985, "edit_id": 3, "question": "What specific substances were measured in the study to understand how the body uses sugar and fats?", "category": "concept", "label": "concept"}, {"doc_id": 5891985, "edit_id": 4, "question": "How much glucose was used in the sugar tolerance test?", "category": "concept", "label": "extent"}, {"doc_id": 5891985, "edit_id": 5, "question": "What were the specific decreases in the levels of harmful fats and the molecule linked to blood vessel damage in the liraglutide group?", "category": "concept", "label": "extent"}, {"doc_id": 5923799, "edit_id": 0, "question": "How long did each Taekwondo session last for the children in the study?", "category": "omission", "label": "extent"}, {"doc_id": 5923799, "edit_id": 1, "question": "What specific tests were used to measure the children's mood and cognitive function?", "category": "omission", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 2, "question": "What specific test was used to measure the children's balance?", "category": "concept", "label": "procedural"}, {"doc_id": 5923799, "edit_id": 3, "question": "What specific aspects of mood were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5923799, "edit_id": 4, "question": "What specific aspects of sociability were measured in the study?", "category": "concept", "label": "concept"}, {"doc_id": 5966460, "edit_id": 0, "question": "Who are the potential users of the microbicides being tested?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 1, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 2, "question": "What were the specific formulations of the Griffithsin gel that were tested?", "category": "omission", "label": "concept"}, {"doc_id": 5966460, "edit_id": 3, "question": "How were the rectal mucosal samples evaluated in the study?", "category": "omission", "label": "procedural"}, {"doc_id": 5966460, "edit_id": 4, "question": "In which gel formulation was an increase in beneficial microbial taxa observed?", "category": "concept", "label": "verification"}, {"doc_id": 5966460, "edit_id": 5, "question": "What specific changes were observed in the placebo gels?", "category": "concept", "label": "consequence"}, {"doc_id": 5976307, "edit_id": 0, "question": "What were the results of the multivariate analysis regarding vital sign fluctuation in the etomidate group?", "category": "omission", "label": "consequence"}, {"doc_id": 5976307, "edit_id": 1, "question": "What is the recommendation for patients with high and low ASA scores?", "category": "omission", "label": "concept"}, {"doc_id": 5976307, "edit_id": 2, "question": "What specific type of muscle twitching was observed more in the etomidate group?", "category": "concept", "label": "consequence"}, {"doc_id": 5976501, "edit_id": 0, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 5976501, "edit_id": 1, "question": "What tools were used to measure the participants' mood and stress levels?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 2, "question": "How was the data from the study analyzed?", "category": "omission", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 3, "question": "How did the researchers search for previous studies on the topic?", "category": "concept", "label": "procedural"}, {"doc_id": 5976501, "edit_id": 4, "question": "How significant was the dose-dependent relationship of 5-ALA intake on measures of effort, loneliness, and coping ability?", "category": "concept", "label": "extent"}, {"doc_id": 5985618, "edit_id": 0, "question": "What is the full name of the treatment that uses controlled temperature radio waves?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 1, "question": "What is the full name of the treatment that uses a type of laser?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 2, "question": "What is the full name of the chronic issue called tonsillitis where there's a cheesy substance in the throat?", "category": "omission", "label": "concept"}, {"doc_id": 5985618, "edit_id": 3, "question": "What specific scale was used to measure the pain levels of the patients?", "category": "concept", "label": "procedural"}, {"doc_id": 5985618, "edit_id": 4, "question": "How was the pain level compared between the group treated with radio waves and the laser group?", "category": "concept", "label": "comparison"}, {"doc_id": 5986443, "edit_id": 0, "question": "What specific conditions associated with aging can lead to loss of muscle mass and strength?", "category": "omission", "label": "example"}, {"doc_id": 5986443, "edit_id": 1, "question": "How much whey protein or placebo did the participants ingest?", "category": "omission", "label": "extent"}, {"doc_id": 5986443, "edit_id": 2, "question": "What aspects of the participants' health were assessed before and after the intervention?", "category": "omission", "label": "procedural"}, {"doc_id": 5986443, "edit_id": 3, "question": "What was the intensity of the weight training program?", "category": "concept", "label": "concept"}, {"doc_id": 5986443, "edit_id": 4, "question": "What statistical method was used to analyze the data in the study?", "category": "concept", "label": "procedural"}, {"doc_id": 5986443, "edit_id": 5, "question": "What specific test was used to measure the participants' functional capacity?", "category": "concept", "label": "procedural"}, {"doc_id": 65514, "edit_id": 0, "question": "What type of drug is Simvastatin and how is it classified in the treatment of high cholesterol?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 1, "question": "What was the design of the study?", "category": "omission", "label": "concept"}, {"doc_id": 65514, "edit_id": 2, "question": "After how long did the researchers observe no significant difference in LDL-cholesterol levels between the two groups?", "category": "concept", "label": "extent"}, {"doc_id": 65514, "edit_id": 3, "question": "Were there any other side effects observed apart from dizziness and nausea?", "category": "concept", "label": "verification"}]